Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | P10 - Poster Session 10

Wednesday 04/17/24
11:45 AM - 12:45 PM MDT Add To Calendar
Colorado Convention Center | Exhibit Hall B-E
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Poster Session
General Neurology, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), Global Health and Neuroepidemiology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuro-ophthalmology/Neuro-otology, Neurocritical Care, Sleep, Neuromuscular and Clinical Neurophysiology (EMG)
View the latest research on a variety of topics. Posters are available in-person or online.
0.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Interactive

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM MDT Abstract 9-001 - Effectiveness and Optimization of Low-sodium Oxybate in Participants with Narcolepsy Switching from Sodium Oxybate: Final Data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav (SEGUE) Study
Douglas S. Fuller
11:45 AM - 12:45 PM MDT Abstract 9-002 - Samelisant (SUVN-G3031) - Topline Results from the Phase-2 Proof-of-Concept Double-blind, Placebo-controlled Study in Patients with Narcolepsy
Ramakrishna Nirogi, PhD
11:45 AM - 12:45 PM MDT Abstract 9-003 - Efficacy of Low-sodium Oxybate by Baseline Sleep Inertia in a Phase 3 Clinical Study in Participants with Idiopathic Hypersomnia
Marisa Whalen
11:45 AM - 12:45 PM MDT Abstract 9-004 - Global Incidence and Clinical Characteristics of Sleeping Paralysis: A Systematic Review and Meta-analysis
Ahmed Said Negida, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 9-005 - Minimal Clinically Important Difference for the Visual Analog Scale for Sleep Inertia Using Data from a Phase 3 Trial of Low-sodium Oxybate for Idiopathic Hypersomnia
Logan D. Schneider, MD
11:45 AM - 12:45 PM MDT Abstract 9-006 - Effects of Oxybate on Sleep, Sleep Architecture, and Disrupted Nighttime Sleep
Jed Black, MD
11:45 AM - 12:45 PM MDT Abstract 9-007 - Actigraphic and Genetic Characterization of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Phenotypes in the UK Biobank
Patrick Ziyun Liu, PhD
11:45 AM - 12:45 PM MDT Abstract 9-008 - Consistent Efficacy of Once-nightly Sodium Oxybate Regardless of Patient Demographic and Baseline Disease Characteristics
Michael J. Thorpy, MD
11:45 AM - 12:45 PM MDT Abstract 9-009 - Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea: Effect Sizes and Numbers Needed to Treat or Harm
Samantha Floam, DMD
11:45 AM - 12:45 PM MDT Abstract 9-010 - The Relationship Between Disordered Sleep and Pain Perception in Patients with Peripheral Neuropathy
Julia Helene Greenberg, MD
11:45 AM - 12:45 PM MDT Abstract 9-011 - 31-year-old Male with Patau Syndrome: A Rare Case of Long-term Survival
Deap Singh Bhandal
11:45 AM - 12:45 PM MDT Abstract 9-012 - Advanced Description of a Large Cohort of Patients with Creutzfeldt-Jakob Disease
Ada Breitenbucher, MD
11:45 AM - 12:45 PM MDT Abstract 9-013 - Factors Influencing Time to Diagnosis of Creutzfeldt Jakob Disease
Kanchan Kumari, MBBS
11:45 AM - 12:45 PM MDT Abstract 9-014 - Application of a Standardized and Reproducible Definition of Rapidly Progressive Dementia
Nihal Satyadev, MD, MPH
11:45 AM - 12:45 PM MDT Abstract 9-015 - Ancillary Service Utilization Patterns in Functional Neurological Disorder Patients: A Retrospective Cohort Study
Marlie Winslow
11:45 AM - 12:45 PM MDT Abstract 9-016 - An Investigation of Maladaptive Health Behavior Engagement and Neurobehavioral and Neurocognitive Outcomes in Former Elite American Football Players
Tahlia Bragg, PhD
11:45 AM - 12:45 PM MDT Abstract 15-001 - A Brain Care Score for Risk of Late-life Depression: Data from the UK Biobank Cohort
Sanjula Dhillon Singh, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 15-002 - A Brain Care Score for Dementia and Stroke: Data from the UK Biobank Cohort
Sanjula Dhillon Singh, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 15-003 - Neurological Manifestations of Long COVID: A Systematic Review
Nithin C. Kurra, MBBS, MPH
11:45 AM - 12:45 PM MDT Abstract 15-004 - Long-term Effect of COVID on the Brain: Systemic Review and Meta-analysis
Ahmed Said Negida, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 3-001 - Safety and Tolerability of Ecopipam in Tourette Syndrome with Psychiatric Comorbidities
Donald Gilbert, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-002 - Evaluating the Need for Intervention in Tourette Syndrome
Sarah Grace Trulove, MBA
11:45 AM - 12:45 PM MDT Abstract 3-003 - Obsessive-compulsive Themes in Children with Tic Disorders Differ from Those in the General Pediatric OCD Population
Irene Malaty, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-004 - Quality of Life in Males and Females with Tic Disorders
Natalia Szejko, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 3-005 - Pharmacodynamics of Eladocagene Exuparvovec and Safety of the SmartFlow Magnetic Resonance-compatible Ventricular Cannula for Administering Eladocagene Exuparvovec in Pediatric Participants
Phillip L. Pearl, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-006 - When Hands Go Rogue: Unravelling the Mystery of Right-sided Alien Hand Syndrome—A case report
Tanishq Kesani
11:45 AM - 12:45 PM MDT Abstract 3-007 - Frequency of Movement disorders in Peruvian Patients with Creutzfeldt-Jakob
Cintia Margoth Armas-Puente
11:45 AM - 12:45 PM MDT Abstract 3-008 - Expanding the Phenotype of BCL11B-related Disorders: A Case Series of Primary Movement Disorders with Literature Review
Ginny Lane, MD Student
11:45 AM - 12:45 PM MDT Abstract 3-009 - Modulatory Effect of Erucin and Its Polymeric Mixed Micelles on 3-nitropropionic Acid-induced Neurodegeneration
Prabhjot Kaur
11:45 AM - 12:45 PM MDT Abstract 3-010 - Effects of Ecopipam on Growth and Development in Juvenile Rats
Stephen Wanaski, PhD
11:45 AM - 12:45 PM MDT Abstract 3-011 - Incidence and Characterization of Delayed-onset Movement Disorders Following Thrombolysis or Thrombectomy for Acute Ischemic Stroke: A Retrospective Cohort Study
Aya Naji Shnawa, MD
11:45 AM - 12:45 PM MDT Abstract 3-012 - Shaping the Future of Neurological Wilson’s Disease Assessment and Monitoring with Novel Digital Biomarkers
Clarissa Gorin, Other
11:45 AM - 12:45 PM MDT Abstract 3-013 - The Treatable Metallic Twists—Siblings with Inherited Hypermanganesemia due to SLC30A10 Mutation
Lakshmi Priya, MD
11:45 AM - 12:45 PM MDT Abstract 3-014 - The Use of Electrophysiology for Movement Disorders: Experience from a Single Academic Center’s Clinical Practice
Katherine Longardner, MD
11:45 AM - 12:45 PM MDT Abstract 3-015 - Rescue Surgery in Elderly Hemifacial Spasm Patients Refractory to Botulinum Toxin
Margaret Tugend
11:45 AM - 12:45 PM MDT Abstract 3-016 - Motivation States for Bodily Movement in Hyperkinetic Movement Disorders: A Scoping Review
Danielle Alyssa Reynolds, MD
11:45 AM - 12:45 PM MDT Abstract 3-017 - Study of Diabetic Striatopathy in Rural Type-2 Diabetic Patients
Mohamed Ibrahim Abdul Aleem, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-018 - A Study on Clinical Profile of Patients Presenting as an Emergency with Movement Disorders to a Tertiary Care Center–A Preliminary Report
Chintha Venkata Sriram, MBBS, MD
11:45 AM - 12:45 PM MDT Abstract 3-019 - Manganese Neurotoxicity in the Setting of Alcoholic Cirrhosis
Anooshah Ata, MD
11:45 AM - 12:45 PM MDT Abstract 12-001 - A Case of Paraneoplastic Trigeminal Neuropathy in the Setting of Renal Cell Carcinoma
Eric Dunn, DO
11:45 AM - 12:45 PM MDT Abstract 12-002 - Rare Case of Complete Facial Diplegia After Botulinum Toxin Injections for Chronic Migraine
Ashhar Ali, DO, FAAN
11:45 AM - 12:45 PM MDT Abstract 12-003 - Post-COVID Hemicrania Continua: A Case Report
Sara Zeccardi, NP
11:45 AM - 12:45 PM MDT Abstract 12-004 - What a Rare Case of a Cerebrospinal Fluid Leak in a Transgender Male Can Teach Us About Idiopathic Intracranial Hypertension
Isaac Smith, DO, MS
11:45 AM - 12:45 PM MDT Abstract 12-005 - SUNCT-like Symptoms Within an Opalski Syndrome: An Atypical Neurological Conundrum
Jose Francisco Ortega Tola, MD
11:45 AM - 12:45 PM MDT Abstract 12-006 - A Case of Refractory Chronic Migraines and Cluster Headaches Responsive to Peripheral Nerve Stimulator
Co Dinh Duong, MD
11:45 AM - 12:45 PM MDT Abstract 12-007 - Correlation of Headache Frequency and Intensity with the Risk of Obstructive Sleep Apnea in Patients with Idiopathic Intracranial Hypertension
Cristina Alejandra Cruz, MD
11:45 AM - 12:45 PM MDT Abstract 12-008 - Occipital Nerve Block Leading to the Discovery of Carcinosarcoma
Ashhar Ali, DO, FAAN
11:45 AM - 12:45 PM MDT Abstract 12-010 - Blinded Epidural Blood Patch for Treating a Man with Antiphospholipid Syndrome and Autoimmune Thrombocytopenia Presenting with Spontaneous Intracranial Hypotension
Gabriela Petersen, MD
11:45 AM - 12:45 PM MDT Abstract 6-001 - Efficacy of Frexalimab on Physical and Psychological Impacts and Fatigue in Relapsing Multiple Sclerosis: Findings from MSIS-29v2 and PROMIS-Fatigue-MS-8a Assessments in a Phase 2 Trial
Patrick Vermersch
11:45 AM - 12:45 PM MDT Abstract 6-002 - Implementation of a Safety Program Initiative for Monitoring Infusion Disease Modifying Therapies for Multiple Sclerosis
Shuvro Roy, MD
11:45 AM - 12:45 PM MDT Abstract 6-003 - OCARINA I, Phase Ib Study: Dose Selection of Subcutaneous Ocrelizumab in Patients with Multiple Sclerosis
Scott Douglas Newsome, DO, FAAN
11:45 AM - 12:45 PM MDT Abstract 6-004 - Health Economic Impact and Highlighted Clinical/Safety Outcomes in 300 Relapsing Multiple Sclerosis Patients Treated with Alemtuzumab in a Single MS Center
Ryan Shannon, NP
11:45 AM - 12:45 PM MDT Abstract 6-005 - Reduced Risk of Progressive Multifocal Leukoencephalopathy (PML) with Natalizumab Extended Interval Dosing (EID) Compared with Every-4-week (Q4W) Dosing: Updated Analysis of the TOUCH® Prescribing Program Database
Lana Zhovtis Ryerson, MD
11:45 AM - 12:45 PM MDT Abstract 6-006 - OLIKOS Study: 6-month Interim Efficacy and Safety in Patients with Relapsing Multiple Sclerosis Who Switched to Subcutaneous Ofatumumab from Intravenous Anti-CD20 Therapies
Enrique Alvarez, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 6-007 - Low Disease Activity Over 4 Years of Ocrelizumab Therapy in Treatment-naive Patients with High-activity, Early-stage Relapsing-remitting Multiple Sclerosis in the ENSEMBLE Study
Hans-Peter Hartung, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 6-008 - Prospective Longitudinal Study of Cladribine Tablets (CLADB Study) Demonstrates Sustained Reduction in Kappa Free Light Chains in Relapsing Multiple Sclerosis (RRMS) at 96 Weeks
Sharmilee Gnanapavan, MB
11:45 AM - 12:45 PM MDT Abstract 6-009 - Ocrelizumab-induced Typhlitis (Neutropenic Enterocolitis)
Dania Mallick, MBBS
11:45 AM - 12:45 PM MDT Abstract 6-010 - Late-onset Severe Neutropenia in a Patient with Relapsing Remitting Multiple Sclerosis Treated with Ocrelizumab
Catherine Tauro, DO
11:45 AM - 12:45 PM MDT Abstract 6-011 - A Two-part, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fenebrutinib (Part A) and the Effect of Fenebrutinib on the QT/QTc Interval in Healthy Participants (Part B)
Maresa Caunt
11:45 AM - 12:45 PM MDT Abstract 6-012 - Safety Patterns over Time with Ozanimod During an Open-label Extension Trial in Patients with Relapsing Multiple Sclerosis
Krzysztof W. Selmaj
11:45 AM - 12:45 PM MDT Abstract 6-013 - Absolute Lymphocyte Count Around Infections During Phase 3 and Open-label Extension Trials of Ozanimod in Participants with Relapsing Multiple Sclerosis
Hans-Peter Hartung, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 6-014 - Safety and Efficacy of Ozanimod in Patients with Early Relapsing Multiple Sclerosis: 1-year Analysis of the ENLIGHTEN Study
Ahmed Z. Obeidat, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 6-015 - Treatment Persistence of Cladribine Tablets Versus Other Oral Disease-modifying Treatments for Multiple Sclerosis: Results from Danish, Norwegian, and Swedish Registries
Gerard Harty
11:45 AM - 12:45 PM MDT Abstract 6-016 - Comparing Longitudinal Changes in Immunoglobulin G and M Profiles in MS Patients Undergoing B-cell Depleting Therapy: A Retrospective Analysis
Himali Bergeron-Vitez
11:45 AM - 12:45 PM MDT Abstract 6-017 - Comparison of Multiple Sclerosis Patients With or Without Rebound Activity After Fingolimod Cessation: Five-Year Clinical Outcomes
Bade Gulec
11:45 AM - 12:45 PM MDT Abstract 6-018 - The Bruton’s Tyrosine Kinase Inhibitor Remibrutinib Exhibits No Impact on Serum Immunoglobulin Levels: Insights from Chronic Spontaneous Urticaria
Robert A. Bermel, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 7-001 - CEINN and REINN - Lessons from Pilot Pathways Programs for Clinical and Research Experiences in Neurology and Neurosurgery
Neishay Ayub, MD
11:45 AM - 12:45 PM MDT Abstract 7-002 - Exploring Brain Health with High School Students: A SIGN Event
Abigail Elizabeth Connor
11:45 AM - 12:45 PM MDT Abstract 7-003 - Combatting “Neurophobia”: A Proposed Preliminary Educational Model to Promote “Neurophilia”
Richard Isacc Suarez
11:45 AM - 12:45 PM MDT Abstract 7-005 - Development of a Clerkship Reflection Session to Address Medical Students’ Misconceptions of the Field of Neurology
Nicholas Fioravante, MD
11:45 AM - 12:45 PM MDT Abstract 7-006 - Impact of Mandatory Neurology Clerkship Experience for Undergraduate Medical Students on Neurology Residency Applications
Patrick Joseph Callaghan
11:45 AM - 12:45 PM MDT Abstract 7-007 - Enhancing Undergraduate Medical Student Neurology Exposure via the Texas A&M College of Medicine's Student Interest Group in Neurology (SIGN) Results in Higher Neurology Residency Matches
Maya Mounir Ramy, MD
11:45 AM - 12:45 PM MDT Abstract 7-008 - Neurophobia Experienced by Medical Students in India
Hayes Fountain
11:45 AM - 12:45 PM MDT Abstract 1-001 - Beyond the Hospital Walls: Unpacking the Complexities of Acute ASM Initiation and Patient Follow-up
Lorena Maria Figueredo Rivas, MD
11:45 AM - 12:45 PM MDT Abstract 1-002 - Complex Enough?: Evaluating Reliability in Rating Medical Complexity of a Vulnerable Group of Patients with Epilepsy
Jonathan Williams, MD
11:45 AM - 12:45 PM MDT Abstract 1-003 - Unleashing the Potential of Telemedicine in Epilepsy: Effectiveness and Patient Preferences
Rani Priyanka Vasireddy, MBBS
11:45 AM - 12:45 PM MDT Abstract 1-004 - Housing Status and Healthcare Utilization in People Presenting with Seizures
Nicole Rosendale, MD
11:45 AM - 12:45 PM MDT Abstract 1-005 - Optimal Care Access Disparities in Adult Non-English-speaking Patients with Drug-resistant Epilepsy
Cindy McKernan, RN
11:45 AM - 12:45 PM MDT Abstract 1-006 - Implementation of Electronic Health Record-based Anxiety and Depression Screening in an Epilepsy Clinic: Description of Theory-based Implementation Strategy and Quantitative Outcomes Using RE-AIM
Paneeni Lohana, DO
11:45 AM - 12:45 PM MDT Abstract 1-007 - Treatment Outcomes and Healthcare Resource Utilization Among People Living with Focal Onset Epilepsy and Deemed to be Drug Resistant in Clinical Practices in the United States
Jiainbin Mao, PhD
11:45 AM - 12:45 PM MDT Abstract 1-008 - Epidemiology of Drug-resistant Epilepsy in Latin America and the Caribbean: Systematic Review Update and Meta-analysis
Niels Victor Pacheco, MD
11:45 AM - 12:45 PM MDT Abstract 1-009 - Does Discharge Diagnosis Determine Risk of Death? Mortality Following Admission to Veterans Health Administration (VHA) Epilepsy Centers of Excellence (ECoE) Epilepsy Monitoring Units (EMUs)
Marissa Kellogg, MD, MPH
11:45 AM - 12:45 PM MDT Abstract 1-010 - Understanding Burden and Health Outcomes Based on Number of Adverse Events in Patients with Lennox-Gastaut Syndrome in Real-world Clinical Practice Settings
Arturo I. Benitez, MD
11:45 AM - 12:45 PM MDT Abstract 1-011 - Incidence of Epilepsy and Results of EEG Testing Within 10 Years of Stroke in US Veterans: A Single-center Cohort Study
Marissa Kellogg, MD, MPH
11:45 AM - 12:45 PM MDT Abstract 1-012 - Evaluation of a Structured Acute Seizure Action Plan in an Outpatient Adult Epilepsy Center
Lucretia Long, CNP
11:45 AM - 12:45 PM MDT Abstract 1-013 - Anterior Temporal Lobectomy: A Cross-sectional Observational Study of Potential Surgical Candidates at a Single Institute
Edward B. Lee Pan, MD
11:45 AM - 12:45 PM MDT Abstract 1-014 - Making the Diagnosis
Shigeru Kaneki
11:45 AM - 12:45 PM MDT Abstract 1-015 - Assessing Cognitive Impairment in Patients with Epilepsy Using the Montreal Cognitive Assessment (MoCA)
Zaid Sofyan Saleh Miqdadi
11:45 AM - 12:45 PM MDT Abstract 1-016 - Management of Anti-seizure Medication in Patients with Drug-resistant Focal Epilepsy Secondary to Focal Cortical Dysplasia Undergoing Epilepsy Surgery in Argentina
Rodrigo Joaquin Sanjinez, Sr., MD
11:45 AM - 12:45 PM MDT Abstract 10-005 - Papilledema a “Misnomer” for Optic Disc Edema: A Single Center Analysis
Nicholas Demas
11:45 AM - 12:45 PM MDT Abstract 10-006 - Treatment Options for Acute/Subacute Patients with m.11778G>A MT-ND4 Leber Hereditary Optic Neuropathy: A Meta-analysis
Nancy J. Newman, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 4-001 - Structural Connectivity Changes in Brain Network After Spinal Cord Injury
Mario Minor Murakami, Jr., MD
11:45 AM - 12:45 PM MDT Abstract 4-002 - Face Validity: Digital Facial Analysis Recapitulates Clinical Findings of Neurological Disease
Alyssa Nylander, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 4-003 - Classification of Subvocalized Letters with a Neural Network Algorithm
Shaumprovo Debnath, Other
11:45 AM - 12:45 PM MDT Abstract 4-004 - Expanding the Lesion Network Mapping of Delusions
Austin Flitton
11:45 AM - 12:45 PM MDT Abstract 4-005 - Remote Monitoring of Motor, Speech, and Cognitive Function in Progressive Supranuclear Palsy
Ram Kinker Mishra, PhD
11:45 AM - 12:45 PM MDT Abstract 4-006 - Exploring Neurophysiology Through Monitoring the ICP Waveforms in Shunted Pregnant Patients with a Non-invasive Device - A Case Series
Raphael Muszkat Besborodco, MD
11:45 AM - 12:45 PM MDT Abstract 4-007 - Functional Neuronal Networks After Cortical Spreading Depolarizations
Miran Oncel
11:45 AM - 12:45 PM MDT Abstract 4-008 - Brain Networks Implicated in Cerebral Achromatopsia
Mazzy Frost Marcucci
11:45 AM - 12:45 PM MDT Abstract 4-009 - Brain Cortical Thickness Across Age and Gender: Data from Ethnically Diverse Cohort of 8,624 Individuals
Sam Hashemi
11:45 AM - 12:45 PM MDT Abstract 4-010 - The Relationship Between Follow-up MRI and Clinical Outcome in Patients with Encephalitis in a Large Academic Hospital
Jorge Cervantes
11:45 AM - 12:45 PM MDT Abstract 4-011 - A Pilot Study to Evaluate the Influence of a Clinician Outreach Effort for VUS Resolution in Limb-Girdle Muscular Dystrophy
Tanya Bardakjian
11:45 AM - 12:45 PM MDT Abstract 4-012 - Postoperative Cervical Spine Radiograph Analysis: Generative Adversarial Networks Which Erase Spinal Instrumentation Improve the Performance of Landmark Detection Models
Yunting Yu
11:45 AM - 12:45 PM MDT Abstract 4-013 - Prospective Study of Extracellular Vesicles in Plasma as Potential Biomarkers for Silent Brain Infarcts
Lincey Alexida Wilson, MD
11:45 AM - 12:45 PM MDT Abstract 4-014 - The eShunt® System: A Novel Minimally Invasive CSF Shunting System for the Treatment of Idiopathic Normal Pressure Hydrocephalus
Adel Malek, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 13-001 - Neuroinvasion of Emerging and Re-emerging Arboviruses: A Scoping Review
Bahadar Singh Srichawla, DO, MS
11:45 AM - 12:45 PM MDT Abstract 13-002 - Cross-reactivity Between Powassan Virus and West Nile Virus in Patients with Encephalitis
Jeffrey Chen, MD
11:45 AM - 12:45 PM MDT Abstract 13-003 - West Nile Virus Rhombencephalitis Mimicking Hypertrophic Olivary Degeneration
Amanda Rubin, DO
11:45 AM - 12:45 PM MDT Abstract 13-004 - EMG Confirmed Axon Motor Polyneuropathy in a Patient with West Nile Virus: A Case Report
Paul Partyka, DO, PhD
11:45 AM - 12:45 PM MDT Abstract 13-005 - West Nile Virus, The New Great Mimic: A Case Series of Neuroinvasive WNV
DaYoung Kim, DO
11:45 AM - 12:45 PM MDT Abstract 13-006 - Complex Case of Neuroinvasive West Nile Virus
Danah Bakir, MD
11:45 AM - 12:45 PM MDT Abstract 13-007 - More than Meets the Eye: An Unusual Case of Opsoclonus-Myoclonus Syndrome Due to West-Nile Virus Encephalitis
Gavin DeFisser
11:45 AM - 12:45 PM MDT Abstract 13-008 - Powassan Virus Encephalitis in Pediatric Patients: A Case Series
Celia Greenlaw, MD
11:45 AM - 12:45 PM MDT Abstract 13-009 - Powassan Virus Infection Presenting as Rapidly Progressive Encephalitis and New-onset Refractory Status Epilepticus (NORSE)
Jenifer Nicole Moceri, DO
11:45 AM - 12:45 PM MDT Abstract 13-010 - East Coast Meets West Coast: A Pennsylvania Case of California Encephalitis with Bilateral Thalamic and Basal Ganglia Lesions
Sathvik S Shastry, MD
11:45 AM - 12:45 PM MDT Abstract 5-001 - A Brain to Heart Chat - Improving Workflows of Implantable Loop Recorder for Cryptogenic Strokes
Yasodara Priyadharsi Senthamarai Siddharthan, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-002 - The Role of microRNAs as Super-early Biomarkers in Acute Ischemic Stroke: Preliminary Data Analysis of a Systematic Review
John Demir
11:45 AM - 12:45 PM MDT Abstract 5-003 - Magnitude of Effect of Low Dose Colchicine, a Newly FDA Approved Treatment for Stroke Prevention
Erica Escalera
11:45 AM - 12:45 PM MDT Abstract 5-004 - Radiomic-based Risk Stratification of Intracranial Aneurysms
Elena Sagues Sese, MD
11:45 AM - 12:45 PM MDT Abstract 5-006 - Large Artery Atherosclerosis and Young Stroke
Himanshu Ashwin Patel, MD
11:45 AM - 12:45 PM MDT Abstract 5-007 - Caroticocavernous Fistulae: A Real World Comparison of Clinicoradiographic Features and Treatment Approaches
Justin E. Vranic, MD
11:45 AM - 12:45 PM MDT Abstract 5-008 - Low-field, Portable Magnetic Resonance Imaging to Assess Hematoma Volume in Traumatic Brain Injury Patients
Julia Zabinska
11:45 AM - 12:45 PM MDT Abstract 5-009 - Impact of Socioeconomic Status on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage
Ariyaporn Haripottawekul
11:45 AM - 12:45 PM MDT Abstract 5-011 - Patent Foramen Ovale Closure for Secondary Stroke Prevention in Patients Aged 60 or Older Is Safe
Brandon May, MD
11:45 AM - 12:45 PM MDT Abstract 5-012 - Susac’s Syndrome, a Rare Cause of Multifocal Neurologic Deficits: A Case Report
Taylor R. Anderson, MD
11:45 AM - 12:45 PM MDT Abstract 5-014 - Stroke Etiology in Young Adults with Substance Abuse
Himanshu Ashwin Patel, MD
11:45 AM - 12:45 PM MDT Abstract 5-015 - Collateral Recruitment and Thrombocytosis in Patients with Acute Embolic Stroke
Mohammed K. Badi, MD
11:45 AM - 12:45 PM MDT Abstract 5-016 - Stroke Mimics: Experience in a Colombian Fourth Level Hospital
Natalia Ramirez Rodriguez
11:45 AM - 12:45 PM MDT Abstract 5-017 - Efficacy of Transcranial Direct Current Stimulation on Patients with Post-stroke Fatigue
Asmaa Zakria Zakria
11:45 AM - 12:45 PM MDT Abstract 5-018 - DADA2 Syndrome Causing Cerebrovascular Ischemic Syndromes in Two Asian Siblings
Yongyao Kong, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-019 - Assessing Effects of Intrathecal Nicardipine on Cerebral Autoregulation and Cortical Activity in Aneurysmal Subarachnoid Hemorrhage
Sithmi Minara Jayasundara
11:45 AM - 12:45 PM MDT Abstract 5-020 - Light-induced Amaurosis Fugax
David Koren, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-021 - Prolonged and Reversible Encephalopathy Secondary to an Arteriovenous Fistula: A Case Report
Zahid Iqbal, MD
11:45 AM - 12:45 PM MDT Abstract 5-022 - Insights into Stroke in Young Adults at a Tertiary Care Level Hospital in Nariño, Colombia: A Four-year Retrospective Analysis
Andres Ricaurte, MD
11:45 AM - 12:45 PM MDT Abstract 5-023 - Clopidogrel Versus Ticagrelor in Dual Antiplatelet Therapy for Intracranial Aneurysm Patients Undergoing Neuroendovascular Treatment: A Systematic Review and Meta-analysis
Ahmed Said Negida, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-024 - Improving Cerebrovascular Reactivity After Carotid Endarterectomy Is Not Accompanied by Improvement in Endothelial Vasodilator Function
Lauri Sakari Soinne, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-025 - Does Frontal Lobe Stroke Influence the Development of Post-stroke Fatigue?
Tyler Spohr
11:45 AM - 12:45 PM MDT Abstract 5-026 - Triglyceride-glucose Index as a Marker for Insulin Resistance and its Association with CTA Collaterals in Acute Ischemic Stroke: A Retrospective Cohort Study
Mohammed Qussay Ali Al-Sabbagh, MD
11:45 AM - 12:45 PM MDT Abstract 5-027 - Quality Improvement Project for Improving Adherence to ICH Severity Documentation Using RapidAI
Vinay Bhushan Reddy Lakki, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-028 - Older Age Is Associated with Frequent Clinical-core Mismatch in Stroke due to Anterior Circulation Large Vessel Occlusion
Lucas Rios Rocha, MD
11:45 AM - 12:45 PM MDT Abstract 5-029 - RESCUE: A Randomized, Blinded, Placebo-controlled, Parallel Group Study Design to Determine the Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy
Supurna Ghosh, PhD
11:45 AM - 12:45 PM MDT Abstract 5-030 - Paroxysmal Nocturnal Hemoglobinuria: A Rare Cause of Ischemic Stroke
Nicholas Bascou
11:45 AM - 12:45 PM MDT Abstract 5-031 - Comparison of Drug-eluting Stents with Bare Metal Stents for the Treatment of Intracranial and Extracranial Atherosclerotic Stenosis: A Systematic Review and Meta-analysis
Sayed Mustafa Mahmood Shah, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-032 - Recurrent Embolic Ischemic Infarcts with Eosinophilia
Kyle Distler
11:45 AM - 12:45 PM MDT Abstract 2-001 - The Association of Social Determinants of Health on Functional Outcome After Intracerebral Hemorrhage
Akashleena Mallick, MD, MBBS
11:45 AM - 12:45 PM MDT Abstract 2-002 - The Fragility Index of Randomized Controlled Trials for Early Blood Pressure Management of Intracerebral Hemorrhage
Cesar Eduardo Escamilla-Ocanas, MD
11:45 AM - 12:45 PM MDT Abstract 2-003 - INdian trial of TRanexamic Acid IN Spontaneous IntraCerebral haemorrhage (INTRINSIC) Trial—Study Protocol
Atul Phillips, MBBS,MD
11:45 AM - 12:45 PM MDT Abstract 2-004 - Different Response to Blood Pressure Reduction in Lobar and Deep Intracerebral Hemorrhage
Maximiliano Alberto Hawkes, MD
11:45 AM - 12:45 PM MDT Abstract 2-005 - Striking Multi-focal Diffusion Restriction with Intracranial Hypertension—Is It CHANTER Syndrome?
Syed Muhammad Owais
11:45 AM - 12:45 PM MDT Abstract 2-006 - Eye Movement Detection Using Electrooculography and Machine Learning in Cardiac Arrest Patients
Chelsea Sykora
11:45 AM - 12:45 PM MDT Abstract 11-001 - Treatment Fluctuations in Patients with Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis on Maintenance Ravulizumab Treatment
Dave Siu Kwan Ho, MD
11:45 AM - 12:45 PM MDT Abstract 11-002 - Effectiveness and Safety of Transitioning to Ravulizumab from Eculizumab in Patients with Generalized Myasthenia Gravis: Evidence from a Global Registry
Guido Sabatella
11:45 AM - 12:45 PM MDT Abstract 11-003 - Drivers of New Rozanolixizumab Treatment Cycles in Patients with Generalized Myasthenia Gravis in the Phase 3 MycarinG and Open-label Extension Studies
Tuan Hoang Vu, MD
11:45 AM - 12:45 PM MDT Abstract 11-004 - Phase 1 Study of Gefurulimab Pharmacokinetics (PK) and Safety Following Delivery Via Autoinjector in Healthy Adults
Olivia Tong, MD
11:45 AM - 12:45 PM MDT Abstract 11-005 - Response to Rozanolixizumab Across Treatment Cycles in Patients with Generalized Myasthenia Gravis: A Post-hoc Analysis
Robert M. Pascuzzi, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-006 - Safety, Efficacy, and Patient Preference for Subcutaneous Zilucoplan in Myasthenia Gravis After Switching from Intravenous Complement Component 5 Inhibitors: An Interim Analysis of a Phase 3b Study
Miriam L. Freimer, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-007 - Analysis of Serious Infections and Malignancy Risk in Myasthenia Gravis: A US Claims Database Study
Jana Podhorna, MD,PhD
11:45 AM - 12:45 PM MDT Abstract 11-008 - Long-term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Participants with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study
James F. Howard, Jr., MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-009 - Achievement of Minimal Symptom Expression and Effect on Disease-specific Measures in Acetylcholine Receptor Antibody-positive Participants with Generalized Myasthenia Gravis Treated with Efgartigimod in ADAPT/ADAPT+
Srikanth Muppidi, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-010 - Fixed-cycle and Continuous Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Study Design of ADAPT NXT
Vera Bril, MD
11:45 AM - 12:45 PM MDT Abstract 11-011 - Patterns of Steroid Use and Outcomes in US Patients with Generalized Myasthenia Gravis (gMG) Receiving C5 Inhibitor Therapy (C5IT)
Karen Yee, PhD
11:45 AM - 12:45 PM MDT Abstract 11-012 - Mortality and Cancer Risk in Patients with Myasthenia Gravis (MG): A Retrospective Study
Shahar Shelly, MD
11:45 AM - 12:45 PM MDT Abstract 11-013 - Initial Development of the Myasthenia Gravis-Health Index (MG-HI): Measuring the Most Prevalent and Impactful Symptoms Identified in Myasthenia Gravis
Charlotte Engebrecht, Other
11:45 AM - 12:45 PM MDT Abstract 11-014 - Effect of Applying Inclusion and Exclusion Criteria of Phase III Complement Inhibitor and FCRN Inhibitor Trials to Acetylcholine Receptor-positive Generalized Myasthenia Gravis Patients in Routine Clinical Care
Nakul Katyal, MD
11:45 AM - 12:45 PM MDT Abstract 11-015 - LUMINESCE, a Phase 3 Study of Satralizumab in Generalized Myasthenia Gravis (gMG): Baseline Characteristics
Ivana Vodopivec, MD
11:45 AM - 12:45 PM MDT Abstract 11-016 - Artificial Intelligence-based Ocular Motor Biomarkers for Myasthenia Gravis Diagnosis
Preetham Bachina
11:45 AM - 12:45 PM MDT Abstract 11-017 - Anti-IL-6 Receptor Antibody Prevents Muscle Weakness in Experimental Autoimmune Myasthenia Gravis Mouse Model
Shota Miyake
11:45 AM - 12:45 PM MDT Abstract 11-018 - Management of Myasthenia Gravis Around the Globe: Consensus Guidelines vs. Realities of Practice
Julia Helene Greenberg, MD
11:45 AM - 12:45 PM MDT Abstract 11-019 - Sentiment Analysis of Digital Conversations Related to Myasthenia Gravis by Race/Ethnicity
Louis Jackson, PharmD
11:45 AM - 12:45 PM MDT Abstract 11-020 - Investigating Immunological Profiles of Thymus in Myasthenia Gravis by scRNA-seq
Yingkai Li, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 14-001 - Validation Process of NMOSDCopilotTM, a Software as a Medical Device (SaMD) for Patients Living with Neuromyelitis Optica Spectrum Disorder
Michael Levy, MD, PhD, FAAN
11:45 AM - 12:45 PM MDT Abstract 14-002 - Burdens of Neuromyelitis Optica Spectrum Disorder: Real-world Perspectives from Caregivers
Shervin Gholizadeh
11:45 AM - 12:45 PM MDT Abstract 14-003 - Infection in NMOSD: Analyzing the Patterns of Infection in the SAkura Studies, Satralizumab Post-marketing Data, and NMOSD US PharMetrics Claims Data
Benjamin M. Greenberg, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 14-004 - Application of NMOSD IPND-2015 Criteria in AQP4-IgG Positive, MOG-IgG Positive and Seronegative Inflammatory Demyelinating Diseases
Samira Apostolos-Pereira
11:45 AM - 12:45 PM MDT Abstract 14-005 - Indirect Treatment Comparison of Ravulizumab Versus Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-Positive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD)
Stacey Clardy, MD, PhD, FAAN
11:45 AM - 12:45 PM MDT Abstract 14-006 - Matching-adjusted Indirect Comparison of Current Treatments for NMOSD and Evaluation of Long-term Effectiveness
Friedemann Paul
11:45 AM - 12:45 PM MDT Abstract 14-007 - Depression and Anxiety in Neuromyelitis Optica Spectrum Disease (NMOSD): Analysis of a National Dataset
Esther Zeng
11:45 AM - 12:45 PM MDT Abstract 14-008 - The Remarkable Efficacy of Topiramate in Treating Oscillopsia in Neuromyelitis Optica Spectrum Disorder: A Video Case Report
Yuanyuan Tan, MD
11:45 AM - 12:45 PM MDT Abstract 14-009 - Eculizumab Therapy in a Seronegative Patient with NMOSD: A Case Report
Alejandra Duque Ramirez, MD
11:45 AM - 12:45 PM MDT Abstract 14-010 - Trends in Management Practices of Seropositive Neuromyelitis Optica Spectrum Disorder: Lessons from a Multicenter Academic Cohort
Leah Zuroff, MD
11:45 AM - 12:45 PM MDT Abstract 14-011 - Frequency of Neuromyelitis Optica Spectrum Disorder Correlated Symptoms: A Pre- and Post-diagnosis Comparison from a National Dataset
Abigail Hailey Sorenson
11:45 AM - 12:45 PM MDT Abstract 14-012 - Transient Neutrophilic Pleocytosis and Hypoglycorrhachia in a Case of Neuromyelitis Optica Spectrum Disorder
Shouri Dirks
11:45 AM - 12:45 PM MDT Abstract 14-013 - Epidemiology of Seropositive Neuromyelitis Optica Spectrum Disorder in a Large US Population
Carlos Eduardo Vervloet Sollero, MD
11:45 AM - 12:45 PM MDT Abstract 14-014 - Fulminant Paraneoplastic Neuromyelitis Optica Spectrum Disorder (NMOSD) with Triple-negative, Aquaporin-4-positive Breast Cancer
Hemali Patel, DO
11:45 AM - 12:45 PM MDT Abstract 14-016 - Relapse Determinants in Seropositive and Seronegative Neuromyelitis Optica Spectrum Disorder
Pakeeran Siriratnam, MBBS
11:45 AM - 12:45 PM MDT Abstract 14-017 - Descriptive Analysis of Clinical Presentation in a Caribbean Hispanic Population with Neuromyelitis Optica Spectrum Disorders (NMO-SD)
Marelisa Albelo Martinez, MD
11:45 AM - 12:45 PM MDT Abstract 14-018 - Importance of Bodily Functions in Neuromyelitis Optica Spectrum Disorder from Neurologists’ Perspective
Rocío Gómez, Other
11:45 AM - 12:45 PM MDT Abstract 14-019 - NMOSD Patients Transitioning from Adolescent to Adult Care: A Multi-institutional Database Analysis in the United States
Melissa Ann Wright, MD
11:45 AM - 12:45 PM MDT Abstract 14-020 - Evaluation of Subcortical Pathology and Association with Cognition in Neuromyelitis Optica Spectrum Disorders with Myelin Water Imaging
Chia-Chen Tsai
11:45 AM - 12:45 PM MDT Abstract 8-001 - Disparities in Timely Child Neurology Outpatient Care Post-inpatient Admission
Alexander Zhao
11:45 AM - 12:45 PM MDT Abstract 8-003 - What Happens After Hemispherectomy? A Qualitative Study of Parental Narratives
Meredith F. Yang
11:45 AM - 12:45 PM MDT Abstract 8-004 - Social Determinants of Health (SDOH) and Context in Initial Access, Symptom Report, and Recovery within Pediatric Mild Traumatic Brain Injury (mTBI) Care
Sydney Alexandra Wing, PhD
11:45 AM - 12:45 PM MDT Abstract 8-005 - Functional Goal Setting for Botulinum Toxin Injections in People with Cerebral Palsy
Laura Gilbert, DO, MBA
11:45 AM - 12:45 PM MDT Abstract 8-006 - Improving Detection of Underlying Neurologic Etiology for Pediatric Cavovarus Foot Deformity: We Can Do Better
Michelle Rose Christie, MD
11:45 AM - 12:45 PM MDT Abstract 8-007 - Case Report: Gait Abnormality as a Presenting Symptom of Scurvy
Sydney Nicolle Carnes
11:45 AM - 12:45 PM MDT Abstract 8-008 - Healthcare Providers’ Practice and Perception on Discussing Life Expectancy with Duchenne Patients and Caregivers: A Mixed Quantitative/Qualitative Survey
Lauren Treat, MD
Faculty Disclosures
Asif Bashir No disclosure on file
Deap Singh Bhandal Mr. Bhandal has received research support from Health Resources and Services Administration.
Devin Michael Davies Mr. Davies has nothing to disclose.
Kathleen Spears, PhD The institution of Dr. Spears has received research support from AmeriCorps - Missouri Community Service Commission.
Dustin Charles Carpenter, MD Dr. Carpenter has nothing to disclose.
Mohammed Arif Hussain, MD No disclosure on file
Ada Breitenbucher, MD Dr. Breitenbucher has nothing to disclose.
Yazan Al-Hasan, MD Dr. Al-Hasan has nothing to disclose.
Justin Hoskin, MD Dr. Hoskin has nothing to disclose.
Stephen Foldes, PhD Dr. Foldes has nothing to disclose.
Vladimir Shvarts, MD Dr. Shvarts has nothing to disclose.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Kanchan Kumari, MBBS Dr. Kumari has nothing to disclose.
Gabriella Rizzo, MD Dr. Rizzo has nothing to disclose.
Daniel Zhou, MD Dr. Zhou has nothing to disclose.
Kaeli Samson Kaeli Samson has nothing to disclose.
Daniel L. Murman, MD, FAAN The institution of Dr. Murman has received research support from Biogen. The institution of Dr. Murman has received research support from EIP Pharma. The institution of Dr. Murman has received research support from Eli Lilly & Co.. The institution of Dr. Murman has received research support from Functional Neuromodulation. The institution of Dr. Murman has received research support from Roche Pharmaceuticals.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Novartis. The institution of Dr. Graff-Radford has received research support from AbbVie. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Nihal Satyadev, MD, MPH Mr. Satyadev has nothing to disclose.
Philip W. Tipton, MD Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Aaron L. Berkowitz, MD, PhD, FAAN Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill Education. Dr. Berkowitz has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Clinical problem Solvers. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Thieme Publisher.
David Galarneau, MD Dr. Galarneau has nothing to disclose.
Marlie Winslow Ms. Winslow has nothing to disclose.
M. Brandon Westover, MD, PhD Dr. Westover has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Tahlia Bragg, PhD The institution of Dr. Bragg has received research support from National Institute of Aging.
Shania Baldwin, Other Miss Baldwin has nothing to disclose.
Minna Holleck Miss Holleck has nothing to disclose.
Erika Pettway, Other Miss Pettway has nothing to disclose.
Fatima Tuz-Zahra Ms. Tuz-Zahra has nothing to disclose.
Yorghos Tripodis Yorghos Tripodis, 5406 has nothing to disclose.
Charles Bernick, MD Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Optina. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corium. Dr. Bernick has stock in Aurora. The institution of Dr. Bernick has received research support from UFC. The institution of Dr. Bernick has received research support from Top Rank Promotions. The institution of Dr. Bernick has received research support from Haymon Boxing.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Jeffrey Lee Cummings, MD, FAAN Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkahest. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Green Valley. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuaka. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for United Neuroscience. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Cummings has received research support from NIH. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Eric M. Reiman, MD Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA.
Martha Shenton Martha Shenton has nothing to disclose.
Robert Stern, PhD Robert Stern, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Robert Stern, PhD has received research support from Eisai. The institution of Robert Stern, PhD has received research support from Lilly. The institution of Robert Stern, PhD has received research support from ATRI/NIA. Robert Stern, PhD has received publishing royalties from a publication relating to health care. Robert Stern, PhD has a non-compensated relationship as a Member with NFLPA Mackey-White Committee that is relevant to AAN interests or activities.
Michael Alosco, PHD The institution of Michael Alosco, PHD has received research support from NIH.
Robert W. Turner, II, PhD The institution of Dr. Turner has received research support from National Institute on Aging of the National Institute of Health.
Aaron Ritter, MD The institution of Dr. Ritter has received research support from NIH.
Jerald Fagliano No disclosure on file
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Elias S. Sotirchos, MD Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sotirchos has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Sotirchos has received research support from National Institutes of Health. The institution of Dr. Sotirchos has received research support from National Multiple Sclerosis Society. The institution of Dr. Sotirchos has received research support from Sumaira Foundation. The institution of Dr. Sotirchos has received research support from Genentech. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Ad Hoc Reviewer with National Institutes of Health.
Loic Carment, PhD Dr. Carment has received personal compensation for serving as an employee of Ad Scientiam.
Clarissa Gorin, Other Dr. Gorin has received personal compensation for serving as an employee of Ad Scientiam.
Lissandra Klaeylé, Other Miss Klaeylé has received personal compensation for serving as an employee of Ad Scientiam.
Dellini Ravindra Miss Ravindra has received personal compensation for serving as an employee of Ad Scientiam.
Emma Touré Cuq, Other Mrs. Touré Cuq has received personal compensation for serving as an employee of Ad Scientiam .
Alizé Vives, Other Dr. Vives has received personal compensation for serving as an employee of Ad Scientiam.
Saad Zinai Saad Zinai has received personal compensation for serving as an employee of Ad Scientiam.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Daniel Lefkowitz No disclosure on file
Anisha Patel, PhD Dr. Patel has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Patel has received personal compensation for serving as an employee of Google. Dr. Patel has stock in Genentech Inc.. An immediate family member of Dr. Patel has stock in Google.
Kathryn Krupsky, PhD Dr. Krupsky has received personal compensation for serving as an employee of Cerner Enviza, an Oracle Company.
Ashley Ann Martin, PhD Dr. Martin has received personal compensation for serving as an employee of Cerner Enviza. The institution of Dr. Martin has received research support from Lundbeck LLC.
Kacper Perkowski Mr. Perkowski has received personal compensation for serving as an employee of Oracle Life Sciences. Mr. Perkowski has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Oracle Life Sciences. Mr. Perkowski has received research support from Oracle Life Sciences.
Patrick Olsen No disclosure on file
Shervin Gholizadeh Mr. Gholizadeh has received personal compensation for serving as an employee of Genentech.
Jacinta Behne Ms. Behne has nothing to disclose.
Megan Behne Ms. Behne has received personal compensation for serving as an employee of The Guthy-Jackson Charitable Foundation. Ms. Behne has received personal compensation in the range of $50,000-$99,999 for serving as a Independent Contractor with The Guthy-Jackson Charitable Foundation.
Kim Jackson-Matthews Mrs. Jackson-Matthews has nothing to disclose.
Lisa McDaniel, Other Mrs. McDaniel has received personal compensation for serving as an employee of The Guthy-Jackson Charitable Foundation.
Cori Woolf Mrs. Woolf has received personal compensation for serving as an employee of The Guthy-Jackson Charitable Foundation.
Michael R. Yeaman, PhD Dr. Yeaman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Yeaman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech-Roche. Dr. Yeaman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Yeaman has received research support from National Institutes of Health. The institution of Dr. Yeaman has received research support from U.S. Department of Defense. Dr. Yeaman has received intellectual property interests from a discovery or technology relating to health care. Dr. Yeaman has received intellectual property interests from a discovery or technology relating to health care.
Lindsay Rechtman The institution of Lindsay Rechtman has received research support from ATSDR.
Kazuo Fujihara, MD Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin.
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. The institution of Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a speaker at internal meeting and symposium with Horizon.
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla.
Ingo Kleiter Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall.
Jacqueline Palace Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, Mitsubushi, UCB, Roche, Novartis, Amplo, Alexion, Chugai, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Chugai. Dr. Palace has stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,.Meddimune, argenx. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Miriam Triyatni, MD,PhD Dr. Triyatni has stock in Roche.
Kathleen Blondeau, PhD Dr. Blondeau has received personal compensation for serving as an employee of F. Hoffmann-La Roche.
Alexander Burdeska, PhD Dr. Burdeska has received personal compensation for serving as an employee of Roche.
INNOCENT Ayu'umbi NGWA, Other Mr. NGWA has received personal compensation for serving as an employee of F. Hoffmann-La Roche . Mr. NGWA has stock in F. Hoffmann-La Roche .
Takashi Yamamura, MD Dr. Yamamura has nothing to disclose.
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/ROche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has stock in GenrAb. Dr. Greenberg has stock in Clene. The institution of Dr. Greenberg has received research support from CLENE Nanomedicine. The institution of Dr. Greenberg has received research support from Anokion. The institution of Dr. Greenberg has received research support from Regeneron. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Gaelle Klingelschmitt Gaelle Klingelschmitt has received personal compensation for serving as an employee of F.Hoffmann-La Roche LTD.
Jeffrey L. Bennett, MD, PhD, FAAN Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Bio. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImCyse. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Podoll. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Patterson. The institution of Dr. Bennett has received research support from Novartis. The institution of Dr. Bennett has received research support from Alexion. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Wendy Eileen Kaye, PhD Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Samira Apostolos-Pereira Samira Apostolos-Pereira has nothing to disclose.
Joao Vitor Mahler Ferreira Oliveira Mr. Mahler Ferreira Oliveira has nothing to disclose.
Guilherme Diogo Silva Mr. Diogo Silva has nothing to disclose.
Vinicius Andreoli Schoeps, MD Dr. Schoeps has nothing to disclose.
Ana Beatriz Ayroza Galvao Ribeiro Gomes, MD Dr. Ayroza Galvao Ribeiro Gomes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Guidepoint. The institution of Dr. Ayroza Galvao Ribeiro Gomes has received research support from Roche.
Natalia Trombini Mendes, MD Dr. Mendes has nothing to disclose.
Aline de Moura Brasil Matos, MD The institution of Dr. Matos has received research support from Hoffmann LaRoche.
Marina Solti Miss Solti has nothing to disclose.
Milena Sales Pitombeira, PhD Mrs. Pitombeira has nothing to disclose.
Mateus Boaventura de Olivei, MD Dr. Boaventura de Olivei has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Boaventura de Olivei has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
CAROLINA DE MEDEIROS Rimkus, MD,PhD Dr. Rimkus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rimkus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Guerbet. Dr. Rimkus has received research support from Multiple Sclerosis International Federatio .
Tarso Adoni, MD, FAAN Dr. Adoni has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Anne-Katrin Proebstel, MD The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Proebstel has received research support from Biogen. Dr. Proebstel has received intellectual property interests from a discovery or technology relating to health care.
Douglas Kazutoshi Sato, MD Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Sato has received research support from Biogen. The institution of Dr. Sato has received research support from Merck.
Dagoberto Callegaro, Sr. Dr. Callegaro has nothing to disclose.
Renata Barbosa Paolilo, MD,PhD Dr. Paolilo has nothing to disclose.
Pedro Bruel Torretta, MD Dr. Torretta has nothing to disclose.
Robert L. Carruthers, MD Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory.
Sean J. Pittock, MD Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care.
Orhan Aktas, MD Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Aktas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Jin Nakahara, MD, PhD Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. The institution of Prof. Nakahara has received research support from EA Pharma. The institution of Prof. Nakahara has received research support from JB. The institution of Prof. Nakahara has received research support from Eisai. The institution of Prof. Nakahara has received research support from Shionogi. The institution of Prof. Nakahara has received research support from Boehringer Ingelheim. The institution of Prof. Nakahara has received research support from Kyowa Kirin. The institution of Prof. Nakahara has received research support from Sumitomo Pharma. The institution of Prof. Nakahara has received research support from Otsuka. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Teijin. The institution of Prof. Nakahara has received research support from Mitsubishi-Tanabe.
Noriko Isobe, MD Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharma. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharma . Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Pharma. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharmaceutical. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichisankyo. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Isobe has received research support from Chugai Pharmaceutical. The institution of Dr. Isobe has received research support from Kyowa Kirin. The institution of Dr. Isobe has received research support from CSL Behring. The institution of Dr. Isobe has received research support from Boehringer Ingelheim. The institution of Dr. Isobe has received research support from Otsuka Pharma. The institution of Dr. Isobe has received research support from Sumitomo Pharmaceutical . The institution of Dr. Isobe has received research support from Eisai.
Diego Centonze Diego Centonze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Diego Centonze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Diego Centonze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Schering. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer Schering. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW Pharmaceuticals. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Diego Centonze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Diego Centonze has received research support from Merck Serono. The institution of Diego Centonze has received research support from Novartis. The institution of Diego Centonze has received research support from BMS.
Jeroen Paul Jansen, PhD Dr. Jansen has received personal compensation for serving as an employee of Precision Medicine Group. Dr. Jansen has stock in Precision Medicine Group.
Sami Fam Sami Fam has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Sami Fam has received personal compensation for serving as an employee of Biogen. Sami Fam has stock in Biogen. Sami Fam has stock in Astra Zeneca.
Adrian Kielhorn Adrian Kielhorn has received personal compensation for serving as an employee of Alexion. Adrian Kielhorn has stock in Alexion.
Jeffrey Yu, PhD Dr. Yu has received personal compensation for serving as an employee of Alexion. Dr. Yu has stock in AstraZeneca.
Ina Zhang Miss Zhang has nothing to disclose.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Friedemann Paul The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe PC (MTPC). The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aarhus University. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CELGENE. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACRELION. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizter. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
FRANCISCO Sorio Vilela Mr. Sorio Vilela has received personal compensation for serving as an employee of Horizon Therapeutics. Mr. Sorio Vilela has stock in Horizon Therapeutics.
Kristina Rae Patterson, MD, PhD Dr. Patterson has received personal compensation for serving as an employee of Hospital of the University of Pennsylvania. Dr. Patterson has stock in Horizon Therapeutics.
Bruce A. C. Cree, MD, PhD, MCR, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. Dr. Cree has received publishing royalties from a publication relating to health care.
Nishi Rampal, MD Dr. Rampal has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Rampal has received stock or an ownership interest from Alexion Pharmaceutical. Dr. Rampal has received intellectual property interests from a discovery or technology relating to health care.
Daniel M. Cimbora, PhD Dr. Cimbora has received personal compensation for serving as an employee of Viela Bio. Dr. Cimbora has received stock or an ownership interest from Viela Bio.
Mikkel Hasse Pedersen, PhD Mr. Pedersen has nothing to disclose.
Brian Curran Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Esther Zeng Miss Zeng has nothing to disclose.
Abigail Hailey Sorenson Ms. Sorenson has nothing to disclose.
Melissa Ann Wright, MD Dr. Wright has nothing to disclose.
Aditi *Use 317067 Sharma, MD Dr. Sharma has nothing to disclose.
Trieste Francis Miss Francis has nothing to disclose.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation .
Tammy L. Smith, MD, PhD The institution of Dr. Smith has received research support from Alexion/AstraZeneca. Dr. Smith has a non-compensated relationship as a participant with Euroimmun Academy, receiving travel support to attend, that is relevant to AAN interests or activities.
Robert P. Lisak, MD, FAAN Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Mirla L. Avila, MD Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Yuanyuan Tan, MD Dr. Tan has nothing to disclose.
Liljana Nedelkoska No disclosure on file
Alejandra Duque Ramirez, MD Dr. Duque Ramirez has nothing to disclose.
Rebecca Romero, MD, FAAN Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Romero has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon.
Hanane Touil, PhD No disclosure on file
Leah Zuroff, MD Dr. Zuroff has received personal compensation in the range of $500-$4,999 for serving as a Speaker with EMD Serono.
Jaeleene Zabala Wijangco Ms. Wijangco has received research support from National Institutes of Health.
Rachel Brandstadter, MD Dr. Brandstadter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Myla D. Goldman, MD, MSC, FAAN Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Seronon. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen, IDEC. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ADAMAS. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., .
Edith Graham, MD Dr. Graham has nothing to disclose.
Rebecca Farber No disclosure on file
Leorah Aude Emmanuelle Freeman, MD, PhD Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-Roche. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for WebMD. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MSAA. The institution of Dr. Freeman has received research support from Genentech. The institution of Dr. Freeman has received research support from NIH/NINDS. The institution of Dr. Freeman has received research support from NIH/NINDS. The institution of Dr. Freeman has received research support from PCORI. The institution of Dr. Freeman has received research support from EMD Serono. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving as a Participant in educational interview with Multiple Sclerosis Association of America.
Navid Valizadeh, MBBS Dr. Valizadeh has nothing to disclose.
Riley Bove, MD, FAAN Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeurologyLive. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Eli Lilly.
Dina Jacobs, MD Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharmaceuticals. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Jacobs has received research support from Biogen . The institution of Dr. Jacobs has received research support from Genentech .
Joyce Benjamins No disclosure on file
Beverly Bealmear No disclosure on file
Xiyan Yi, MD Dr. Yi has nothing to disclose.
Shouri Dirks Miss Dirks has nothing to disclose.
Jiannan Huang, MD Dr. Huang has nothing to disclose.
Baker Alkhairi, MD Dr. Alkhairi has nothing to disclose.
Riu Li No disclosure on file
Kavita Nair, PhD, FAAN Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Healthcare. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS.
Aaron M. Carlson, MD Dr. Carlson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Carlson has received research support from Horizon Therapeutics. Dr. Carlson has a non-compensated relationship as a Health Service Subcommittee Member with American Academy of Neurology that is relevant to AAN interests or activities.
Stefan Sillau The institution of Stefan Sillau has received research support from Alzheimer's Association. The institution of Stefan Sillau has received research support from Hewitt Family Foundation; State of Colorado. The institution of Stefan Sillau has received research support from PCORI. The institution of Stefan Sillau has received research support from NINR. The institution of Stefan Sillau has received research support from Michael J. Fox Foundation. The institution of Stefan Sillau has received research support from Department of Defense. The institution of Stefan Sillau has received research support from Colorado Department of Public Health and Environment. The institution of Stefan Sillau has received research support from Benign Essential Blepharospasm Research Foundation. Stefan Sillau has a non-compensated relationship as a Statistician with Novartis that is relevant to AAN interests or activities. Stefan Sillau has a non-compensated relationship as a Statistician with Biogen that is relevant to AAN interests or activities.
Carlos Eduardo Vervloet Sollero, MD Dr. Vervloet Sollero has nothing to disclose.
Amanda Lee Piquet, MD, FAAN The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Novartis. The institution of Dr. Piquet has received research support from Abbvie. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Kelli Money, MD, PhD Dr. Money has nothing to disclose.
Barrie Schmitt, MD Dr. Schmitt has nothing to disclose.
H[eacute]toum Misirliyan No disclosure on file
Ibrahim Noorbhai, DO Dr. Noorbhai has nothing to disclose.
Fernando Xavier Cuascut Lassus, MD Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving as a Speaker with MSAA.
Joseph S. Kass, MD, JD, FAAN Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care.
Hemali Patel, DO Dr. Patel has nothing to disclose.
Rebeka Bustamante Rocha, Other Mrs. Bustamante Rocha has nothing to disclose.
Fernanda Ferreira Bomtempo, MD Dr. Bomtempo has nothing to disclose.
Ana Claudia Benevides Tadinac, MD Mrs. Benevides Tadinac has nothing to disclose.
Joao Paulo Mota Telles, MD,PhD Dr. Telles has nothing to disclose.
Sharon Chiang, MD, PhD Dr. Chiang has stock in EpilepsyAI. Dr. Chiang has received research support from UCSF Clinical and Translational Science Institute UL1 TR001872. The institution of Dr. Chiang has received research support from NIH R25 NS070680 .
Pakeeran Siriratnam, MBBS Dr. Siriratnam has nothing to disclose.
Paul Sanfilippo, PhD Dr. Sanfilippo has nothing to disclose.
Saif Huda, MD Dr. Huda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Guidepoint.
Sifat Sharmin, PhD Dr. Sharmin has nothing to disclose.
Tomas Kalincik Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group vice-chair with MSBase Foundation that is relevant to AAN interests or activities.
Anneke *Use 169590 Van Der Walt, PhD,FRACP,MBBS Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Van Der Walt has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase Foundation. The institution of Dr. Van Der Walt has received research support from NHMRC Australia. The institution of Dr. Van Der Walt has received research support from MS Australia.
Vilija *use 211877 Jokubaitis, PhD Prof. Jokubaitis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Prof. Jokubaitis has received research support from F.Hoffman La-Roche. The institution of Prof. Jokubaitis has received research support from National Health and Medical Research Council of Australia (NHMRC). The institution of Prof. Jokubaitis has received research support from Multiple Sclerosis Australia.
Helmut Butzkueven, MD, MBBS Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Mastura Monif, PhD, MBBS Dr. Monif has nothing to disclose.
Marelisa Albelo Martinez, MD Dr. Albelo Martinez has nothing to disclose.
Jazmín Sotomayor Ortiz Mrs. Sotomayor Ortiz has nothing to disclose.
Jose Avila-Ornelas, MD Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Banner Pharmaceuticals.
Gishlaine Alfonso, MD, FAAN Dr. Alfonso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion .
Jerome Engel, Jr., MD, PhD, FAAN Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebel. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Engel has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Engel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Steven Barris. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cutler Law Firm. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care.
Rocío Gómez, Other Ms. Gómez has received personal compensation for serving as an employee of Roche Farma Spain, Medical Department.
Nieves Tellez Nieves Tellez has nothing to disclose.
Marta Aguado Valcarcel Marta Aguado Valcarcel has nothing to disclose.
Maria Sepúlveda Maria Sepúlveda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Maria Sepúlveda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HORIZON THERAPEUTICS. Maria Sepúlveda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Sepúlveda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Sepúlveda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial.
Alvaro Cobo Calvo, PhD,MD Dr. Cobo Calvo has nothing to disclose.
Aida Orviz-García, MD Dr. Orviz-García has nothing to disclose.
Maria Diaz Sanchez Maria Diaz Sanchez has nothing to disclose.
Sabas Boyero Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Pablo Rebollo, MD Dr. Rebollo has nothing to disclose.
Jorge Maurino Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Harvey S. Levin, PhD No disclosure on file
Zulfi Haneef, MD, MBBS, MRCP, FAAN Dr. Haneef has nothing to disclose.
Chia-Chen Tsai Ms. Tsai has received research support from Foundation of the Consortium of Multiple Sclerosis Centers. Ms. Tsai has received research support from UBC Multiple Sclerosis Connect Program.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme.
Shannon Kolind, PhD, MSc, BSc Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen.
Anna Combes No disclosure on file
Inigo *use273113 Gabilondo No disclosure on file
Yasodara Priyadharsi Senthamarai Siddharthan, MBBS Dr. Senthamarai Siddharthan has nothing to disclose.
Jessica Doyle Lee, MD, FAAN Dr. Lee has received personal compensation for serving as an employee of American Academy of Neurology.
Margie Campbell, IV, RN Mrs. Campbell has nothing to disclose.
Robyn Huebsch, RN Mrs. Huebsch has received personal compensation for serving as an employee of Viz.ai.
Stephanie Rubenstein, RN Ms. Rubenstein has received personal compensation for serving as an employee of Viz.ai. Ms. Rubenstein has stock in Viz.ai.
Christopher Love Dr. Love has received personal compensation for serving as an employee of Viz.ai.
Ryan Babayev No disclosure on file
John Demir Mr. Demir has nothing to disclose.
Jonatan Hornik, MD Dr. Hornik has nothing to disclose.
Alejandro Hornik, MD Dr. Hornik has nothing to disclose.
Ashmeet Singh Sahni, MD Dr. Sahni has nothing to disclose.
Andrea Loggini, MD, MBA Dr. Loggini has nothing to disclose.
Santiago Bullich No disclosure on file
Mohammed Qussay Ali Al-Sabbagh, MD Dr. Al-Sabbagh has nothing to disclose.
Hussein Alsadi, MBBS Dr. Alsadi has nothing to disclose.
Prasanna Venkatesan Eswaradass, MD Dr. Eswaradass has nothing to disclose.
Marc Figueras-Roca No disclosure on file
Andres Gudino Mr. Gudino has nothing to disclose.
Arshaq Saleem The institution of Mr. Saleem has received research support from National Institutes of Health.
Sricharan Veeturi, PhD Dr. Veeturi has nothing to disclose.
Diego Ojeda, Jr., MD Dr. Ojeda has nothing to disclose.
Elena Sagues Sese, MD Dr. Sagues Sese has nothing to disclose.
Sebastian Sanchez No disclosure on file
Fausto Carlos Dier Melo, MD Dr. Dier Melo has nothing to disclose.
Samantha Saenz Hinojosa, MD Dr. Saenz Hinojosa has nothing to disclose.
Ariel Vargas, MD Dr. Vargas has nothing to disclose.
Edgar A. Samaniego, MD, FAAN Dr. Samaniego has nothing to disclose.
Albert Saiz Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Sheharyar Baig Dr. Baig has received research support from Association of British Neurologists (The Stroke Association and The Berkeley Foundation).
Ali Alhashimi, Other Mr. Alhashimi has nothing to disclose.
Ryta Kamarova, MBBS Dr. Kamarova has nothing to disclose.
Krishnan Padmakumari S Nair The institution of Dr. Nair has received research support from MS socety. The institution of Dr. Nair has received research support from JP Moulten Charitable trust. Dr. Nair has received publishing royalties from a publication relating to health care.
Jessica Redgrave Dr. Redgrave has nothing to disclose.
Arshad Majid, MD Dr. Majid has received publishing royalties from a publication relating to health care.
Ali Ali Dr. Ali has nothing to disclose.
Bernardo Sanchez-Dalmau No disclosure on file
Himanshu Ashwin Patel, MD Dr. Patel has nothing to disclose.
Keyvan Heshmati, MD Dr. Heshmati has nothing to disclose.
Kathleen Ryan Ms. Ryan has nothing to disclose.
Karen Yarbrough Karen Yarbrough has nothing to disclose.
Lakeisha M. Mixon Miss Mixon has nothing to disclose.
Devin Williams Devin Williams has nothing to disclose.
Steven J. Kittner, MD, MPH The institution of Dr. Kittner has received research support from NINDS.
Carolyn Cronin, MD, PhD, FAAN Dr. Cronin has nothing to disclose.
Pablo Villoslada, MD, PhD, FAAN Dr. Villoslada has received personal compensation for serving as an employee of Attune Neuroscience. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accure Therapeutics. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has stock in Attune Neurosciences. Dr. Villoslada has stock in Bionure Investments. Dr. Villoslada has stock in Spiral Therapeutics. Dr. Villoslada has stock in Adhera Health. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from NIH. The institution of Dr. Villoslada has received research support from Department of Defense. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care.
Justin E. Vranic, MD Dr. Vranic has nothing to disclose.
Amine Mohamed Marc Awad, BM BCh Dr. Awad has nothing to disclose.
James D. Rabinov James D. Rabinov has stock in Pfizer.
Robert W. Regenhardt, MD, PhD Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Neeta S. Duggal, MD No disclosure on file
Julia Zabinska Ms. Zabinska has nothing to disclose.
Vineetha Yadlapalli Miss Yadlapalli has nothing to disclose.
Mercy Hope Mazurek Miss Mazurek has nothing to disclose.
Nethra Parasuram, Other Ms. Parasuram has nothing to disclose.
Dheeraj Devkrishin Lalwani Mr. Lalwani has nothing to disclose.
Emma Sylvaine Peasley Miss Peasley has nothing to disclose.
Emily Jean Gilmore, MD Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Jennifer A. Kim, MD Dr. Kim has nothing to disclose.
Sacit Bulent Omay, MD Dr. Omay has nothing to disclose.
Gordon Sze Gordon Sze has nothing to disclose.
Sam Payabvash Sam Payabvash has nothing to disclose.
Annabel Sorby-Adams, PhD The institution of Dr. Sorby-Adams has received research support from American Heart Association. Dr. Sorby-Adams has received research support from Fulbright Commission Australia.
Jua Eugenio Iglesias Gonzalez, PhD Dr. Iglesias Gonzalez has nothing to disclose.
Matthew Rosen Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DeepSpin. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chipiron. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synex. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nanalysis. Matthew Rosen has stock in Hyperfine Inc.. Matthew Rosen has stock in Vizma Life Sciences. Matthew Rosen has stock in Intact Data Services. Matthew Rosen has stock in DeepSpin. The institution of Matthew Rosen has received research support from GE HealthCare. The institution of Matthew Rosen has received research support from Imagion Biosystems. Matthew Rosen has received intellectual property interests from a discovery or technology relating to health care.
W. Taylor Kimberly, MD, PhD Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hyperfine Inc.. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from Biogen. The institution of Dr. Kimberly has received research support from NControl Therapeutics. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from American Heart Association. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care.
Kevin N. Sheth, MD, FAAN Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Trenton M. Myers, MD No disclosure on file
Ariyaporn Haripottawekul Miss Haripottawekul has nothing to disclose.
Kareem Joudi Mr. Joudi has nothing to disclose.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Ali Mahta, MD Dr. Mahta has nothing to disclose.
James Everett Kim, MD No disclosure on file
Sigmund Lilian, MD Dr. Lilian has nothing to disclose.
Mary Carter Denny, MD Dr. Denny has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Laboratory. The institution of Dr. Denny has received research support from NIDDILIR. Dr. Denny has received publishing royalties from a publication relating to health care.
Lowell Satler Dr. Satler has nothing to disclose.
Thomas E. MacGillivray, MD Dr. MacGillivray has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Society of Thoracic Surgeons.
Iftekhar Ahmed, MD, PC, FAAN Dr. Ahmed has nothing to disclose.
Brandon May, MD Dr. May has nothing to disclose.
Michael F. Waters, MD, PhD, FAAN Dr. Waters has nothing to disclose.
Vijendra Swarup No disclosure on file
Hursh Naik, MD Dr. Naik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for abbott. Dr. Naik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbott.
Daniel Gonzalez, MD Dr. Gonzalez has nothing to disclose.
Supreet Kaur, MD Dr. Kaur has nothing to disclose.
Lynn Stuart Ashby, MD Dr. Ashby has nothing to disclose.
Patricia Teran Miss Teran has nothing to disclose.
Tracie Schroeder, RN Ms. Schroeder has nothing to disclose.
Tiffany Sheehan Tiffany Sheehan has nothing to disclose.
Emily Mawk, Other Ms. Mawk has nothing to disclose.
David Z. Wang, DO, FAAN, FAHA Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Mediwelcome.
Ira R. Casson, MD Dr. Casson has nothing to disclose.
Nicholas Liquigli, DO Dr. Liquigli has nothing to disclose.
Taylor R. Anderson, MD Dr. Anderson has nothing to disclose.
Lauren Turner, DO Dr. Turner has nothing to disclose.
Christopher Michael Goshgarian, MD Dr. Goshgarian has nothing to disclose.
Baljit Singh Deol, MD Dr. Deol has nothing to disclose.
Muhammad Farooq, MD Dr. Farooq has nothing to disclose.
David Viano No disclosure on file
Ali Emami Mr. Emami has nothing to disclose.
Sepideh Paybast, MD Dr. Paybast has nothing to disclose.
E. Haacke No disclosure on file
Zhifeng Kou No disclosure on file
Mohammed K. Badi, MD Dr. Badi has nothing to disclose.
Bhrugun Anisetti, MBBS Dr. Anisetti has nothing to disclose.
Esraa Sobhy Masoud M Elsayed Miss Elsayed has nothing to disclose.
Michelle P. Lin, MD Dr. Lin has nothing to disclose.
Md Manjurul Islam Shourav Mr. Shourav has nothing to disclose.
Amra Sakusic, MD Dr. Sakusic has nothing to disclose.
Danielle LeStrange No disclosure on file
Natalia Ramirez Rodriguez Ms. Ramirez Rodriguez has nothing to disclose.
Camilo Romero No disclosure on file
Asmaa Zakria Zakria No disclosure on file
Yongyao Kong, MBBS Dr. Kong has nothing to disclose.
Hoe Chin Chua, MD No disclosure on file
Sithmi Minara Jayasundara Miss Jayasundara has nothing to disclose.
Rachel Sera Choi Ms. Choi has nothing to disclose.
Amedeo Rapuano, Other Mr. Rapuano has nothing to disclose.
Erin Barnes, MD Dr. Barnes has nothing to disclose.
Melvin Parasram, MD Dr. Parasram has nothing to disclose.
Michele Moura, Other Dr. Moura has nothing to disclose.
Puneet Kumar Uppal Mr. Uppal has nothing to disclose.
Yilun Chen Ms. Chen has nothing to disclose.
Ilayda Top Ms. Top has nothing to disclose.
Madelynne Olexa Miss Olexa has nothing to disclose.
Rafael Seth Maarek Mr. Maarek has nothing to disclose.
Jennifer Yan, Other Miss Yan has nothing to disclose.
Rachel Beekman, MD Dr. Beekman has nothing to disclose.
Jessica Magid-Bernstein, MD, PhD Dr. Magid-Bernstein has nothing to disclose.
Ryan Hebert Ryan Hebert has nothing to disclose.
Farhad Bahrassa, MD Dr. Bahrassa has nothing to disclose.
Charles Matouk Charles Matouk has nothing to disclose.
Nils Petersen, MD Dr. Petersen has received research support from NIH.
Rocio Carolina Garcia Santibanez, MD, FAAN Dr. Garcia Santibanez has nothing to disclose.
Jiaying Zhang, MD Dr. Zhang has nothing to disclose.
David Koren, MD, PhD Dr. Koren has nothing to disclose.
Stephen N. Scelsa, MD No disclosure on file
Abdalla Albanna, MBBS Dr. Albanna has nothing to disclose.
Ammar Abdulraheem Ah Jumah, MD Dr. Jumah has nothing to disclose.
Michael Fana, MD Mr. Fana has nothing to disclose.
Momina Qureshi Miss Qureshi has nothing to disclose.
Utkarsh Agarwal, MBBS Dr. Agarwal has nothing to disclose.
Daniel Miller, MD Dr. Miller has nothing to disclose.
Thanya Mariselle Lagos, Jr., MD Miss LAGOS has nothing to disclose.
Gabriel Bravo, Sr., MD Dr. Bravo has nothing to disclose.
Yojan Andres Ceballos-Grijalba, MD Dr. Ceballos-Grijalba has nothing to disclose.
Monica Yolanda Pantoja, MD Prof. PANTOJA has nothing to disclose.
Jorge Sebastian Mora Reinel Dr. Mora Reinel has nothing to disclose.
Angela Catalina Vallejo Cajigas, MD Dr. Vallejo Cajigas has nothing to disclose.
Sebastian Rosero Noguera, Sr., MD Dr. ROSERO NOGUERA has nothing to disclose.
Andres Ricaurte, MD Dr. Ricaurte has nothing to disclose.
Nabil Altememi, MD No disclosure on file
Mostafa Hossam El Din Moawad, Other Dr. El Din Moawad has nothing to disclose.
Ibraheem Mashhour Alkhawaldeh, MD Dr. Alkhawaldeh has nothing to disclose.
Abdulrahman Sharaf, Other Dr. Sharaf has nothing to disclose.
Sumaya Fayz Alsalah, MD Mrs. Alsalah has nothing to disclose.
Mohamed Smail Aissani, Sr., MD Dr. Aissani has nothing to disclose.
Mona Mahmoud Elsakka Dr. Elsakka has nothing to disclose.
Ibrahim *USE ID 385479 Serag Dr. Serag has nothing to disclose.
Osama Bisht, MD Dr. Bisht has nothing to disclose.
Ahmed Said Negida, MD, PhD Dr. Negida has nothing to disclose.
Lauri Sakari Soinne, MD, PhD Dr. Soinne has nothing to disclose.
Suvi Maaria Koskinen, MD,PhD Dr. Koskinen has nothing to disclose.
Petra Ijas, MD Petra Ijas, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen.
Krista Nuotio Krista Nuotio has nothing to disclose.
Pirkka Vikatmaa, MD,PhD Dr. Vikatmaa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medistim. Dr. Vikatmaa has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for European Society for Vascular Surgery. Dr. Vikatmaa has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Finnish Society of Surgery.
Perttu Johannes Lindsberg, MD The institution of Dr. Lindsberg has received research support from Helsinki University Hospital District. The institution of Dr. Lindsberg has received research support from Sigrid Juselius foundation.
Hai Chen, MD, PhD Dr. Chen has nothing to disclose.
Steven R. Levine, MD, FAHA Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Yohannes Simeneh Mulatu, MD Dr. Mulatu has nothing to disclose.
Tyler Spohr Mr. Spohr has nothing to disclose.
Srinath Ramaswamy, MD Dr. Ramaswamy has nothing to disclose.
Mohamed Mahmoud Eldokmak, MD Dr. Eldokmak has nothing to disclose.
Vinay Bhushan Reddy Lakki, MBBS Dr. Lakki has nothing to disclose.
Abhishek Singh, MD Dr. Singh has nothing to disclose.
Himanshu Verma, MBBS Dr. Verma has nothing to disclose.
Mittal Sukhdev Prajapati, MD Dr. Prajapati has nothing to disclose.
Hizir Ulvi, MD No disclosure on file
Lucas Rios Rocha, MD Dr. Rios Rocha has nothing to disclose.
Marcelo Rocha, MD, PhD The institution of Dr. Rocha has received research support from NIH.
Mohamed Fahmy Doheim Mr. Doheim has nothing to disclose.
Raul G. Nogueira, MD Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus.
Mohammad Nathier Kayyali, MD Dr. Kayyali has nothing to disclose.
Jay H. Bauman, PharmD No disclosure on file
Supurna Ghosh, PhD Dr. Ghosh has received personal compensation for serving as an employee of Revalesio Corporation.
Jordan Scott Dubow, MD Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avadel Pharmaceuticals.
Jocelyn Sutherland, Other Ms. Sutherland has received personal compensation for serving as an employee of Revalesio.
Andreas Kalmes, PhD Dr. Kalmes has received personal compensation for serving as an employee of Revalesio.
Grayson Baird Grayson Baird has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Incrediwear Holdings. Grayson Baird has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RSNA. The institution of Grayson Baird has received research support from Revalesio.
Jarrad Mock Mr. Mock has received personal compensation for serving as an employee of Revalesio Corporation.
Wendy J. Smith Ms. Smith has nothing to disclose.
Douglas J. Cook Douglas J. Cook has nothing to disclose.
Tracy E *Use 391712 Madsen The institution of Tracy E Madsen has received research support from NHLBI.
Mahesh Jayaraman Mahesh Jayaraman has nothing to disclose.
Krisztina Moldovan, MD Dr. Moldovan has nothing to disclose.
Radmehr Torabi, MD Dr. Torabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Silk Road Medical.
Sameer Ansari No disclosure on file
Christopher George Favilla, MD The institution of Dr. Favilla has received research support from National Institutes of Health. The institution of Dr. Favilla has received research support from American Heart Association. The institution of Dr. Favilla has received research support from OpenWater, Inc..
David Chiu, MD Dr. Chiu has nothing to disclose.
Wayne M. Clark, MD Dr. Clark has nothing to disclose.
David S. Liebeskind, MD, FAAN Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Ryan A McTaggart Ryan A McTaggart has nothing to disclose.
Niki Oquist No disclosure on file
Mona Bahouth, MD The institution of Dr. Bahouth has received research support from American Heart Association. The institution of Dr. Bahouth has received research support from NIH.
Nicholas Bascou Nicholas Bascou has nothing to disclose.
Susanne Gonzalez, MD No disclosure on file
Sayed Mustafa Mahmood Shah, MBBS Dr. Shah has nothing to disclose.
Maheen Kalwar Miss Kalwar has nothing to disclose.
Umer Usman Malik Mr. Malik has nothing to disclose.
Eisha Tur. Raazia Dr. Tur. Raazia has nothing to disclose.
Midori Memon Ms. Memon has nothing to disclose.
Rabia Zafar, MBBS Miss Zafar has nothing to disclose.
Afrah Hassan, MBBS Dr. Hassan has nothing to disclose.
Osama Muhammad Alam, MBBS Mr. Muhammad Alam has nothing to disclose.
Sanjana Rani, MBBS Miss Rani has nothing to disclose.
Aiman Azam Qureshi, MBBS Miss Qureshi has nothing to disclose.
Nicholas R. Mathenia, DO No disclosure on file
Maryam Zulfiqar, MD Dr. Zulfiqar has nothing to disclose.
Kyle Distler Mr. Distler has nothing to disclose.
Parneet Kaur Grewal, MD Dr. Grewal has nothing to disclose.
Chirantan Banerjee, MD, MPH Dr. Banerjee has nothing to disclose.
Sanjay Pandey, MD No disclosure on file
Alexander Zhao Mr. Zhao has nothing to disclose.
Zachary Grinspan, MD Dr. Grinspan has received personal compensation for serving as an employee of Weill Cornell Medicine. Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha Insights. Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharma LTD (South Korea). Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded Therapeutics. The institution of Dr. Grinspan has received research support from SLC6A1 Connect. The institution of Dr. Grinspan has received research support from STXBP1 Foundation. The institution of Dr. Grinspan has received research support from Clara Inspired. The institution of Dr. Grinspan has received research support from Horizon Therapeutics. The institution of Dr. Grinspan has received research support from NINDS. Dr. Grinspan has received intellectual property interests from a discovery or technology relating to health care.
Natasha Basma Natasha Basma has nothing to disclose.
Sarah Chowdhury Miss Chowdhury has nothing to disclose.
Carson Gundlach Mr. Gundlach has nothing to disclose.
Ashwin Mahesh Mr. Mahesh has nothing to disclose.
Nuran *use391237 Golbasi, Other Miss Golbasi has nothing to disclose.
Dinesh Sharma No disclosure on file
Xiaofan Huang Ms. Huang has nothing to disclose.
Sujal Manohar Ms. Manohar has nothing to disclose.
Ellen Jean Fremion, MD Dr. Fremion has nothing to disclose.
Jonathan Castillo No disclosure on file
Heidi Castillo, MD Dr. Castillo has nothing to disclose.
Kristen Staggers, Other Ms. Staggers has nothing to disclose.
Robert Hoepner Robert Hoepner has nothing to disclose.
Meredith F. Yang Ms. Yang has nothing to disclose.
Sandi Lam, MD Dr. Lam has nothing to disclose.
Kayla Tahirih Byrne Miss Byrne has nothing to disclose.
Jonas Ahlbrecht No disclosure on file
Sydney Alexandra Wing, PhD Dr. Wing has nothing to disclose.
Christopher Giza, MD, FAAN Dr. Giza has stock in Highmark Interactive. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care.
Neil Avinash Bhathela, MD Dr. Bhathela has nothing to disclose.
Talin Babikian Talin Babikian has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Various. The institution of Talin Babikian has received research support from NINDS.
Natalie Alexandra Gavi, RD Ms. Gavi has nothing to disclose.
Philip Rosenbaum Mr. Rosenbaum has received research support from Region IV Training Center.
Joshua Caiquo, Other Dr. Caiquo has nothing to disclose.
Daniel Ignacio, PhD Dr. Ignacio has nothing to disclose.
Bradley Barney, PhD The institution of Dr. Barney has received research support from NIH. The institution of Dr. Barney has received research support from HRSA. The institution of Dr. Barney has received research support from Biogen. The institution of Dr. Barney has received research support from Owlet. The institution of Dr. Barney has received research support from National Multiple Sclerosis Society. The institution of Dr. Barney has received research support from Four Corners Youth Consortium members (UCLA, Seattle Children's, Children's National, UT Southwestern, University of Utah). The institution of Dr. Barney has received research support from Intermountain HealthCare. The institution of Dr. Barney has received research support from Johns Hopkins.
Faustina France-Nkansah Ms. France-Nkansah has nothing to disclose.
Ruth Schneider Ruth Schneider has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche Pharma AG. Ruth Schneider has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion Pharma.
Laura Gilbert, DO, MBA Dr. Gilbert has nothing to disclose.
Bhooma Rajagopalan Aravamuthan, MD, PhD Dr. Aravamuthan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. An immediate family member of Dr. Aravamuthan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life Science, Inc.. Dr. Aravamuthan has received research support from National Institute of Neurological Disorders and Stroke. Dr. Aravamuthan has received publishing royalties from a publication relating to health care.
Stefanie Dahlhaus No disclosure on file
Michelle Rose Christie, MD Dr. Christie has nothing to disclose.
Anthony Ian Riccio, MD Dr. Riccio has received publishing royalties from a publication relating to health care. Dr. Riccio has received personal compensation in the range of $500-$4,999 for serving as a Speaker at Industry Sponsored Educational Symposia with Orthopediatrics Inc.
Rusty Lynn Hartman, Other Mr. Hartman has nothing to disclose.
Jacob Zide, MD Dr. Zide has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orthofix, Inc..
Michael O'Sullivan, MD Dr. O'Sullivan has nothing to disclose.
Ortwin Adams No disclosure on file
Sydney Nicolle Carnes Mrs. Carnes has nothing to disclose.
John Kearfott Mr. Kearfott has nothing to disclose.
Gogi Kumar, MD Dr. Kumar has nothing to disclose.
Laura Daniela Fonseca, Other Miss Fonseca has nothing to disclose.
Araam Abboud Ms. Abboud has nothing to disclose.
Andrew H K Chan, MD No disclosure on file
Ty Copeland, Other Mr. Copeland has nothing to disclose.
Aravindhan Veerapandiyan, MD Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AMO Pharma, AveXis, Biogen, Edgewise Therapeutics, FibroGen, Novartis, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Scholar Rock, Catalyst, Lupin. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Lauren Treat, MD Dr. Treat has nothing to disclose.
Rachel Schrader, NP Mrs. Schrader has nothing to disclose.
Ellen Wagner Miss Wagner has received personal compensation for serving as an employee of Parent Project Muscular Dystrophy.
Rebeca Aragon-Garcia No disclosure on file
Matthew Anderson Matthew Anderson has nothing to disclose.
Neishay Ayub, MD The institution of Dr. Ayub has received research support from Brown Physicians Incorporated. The institution of Dr. Ayub has received research support from Pappitto Opportunity Connection.
Tina Mariko Burton, MD Dr. Burton has nothing to disclose.
Yeseon Moon No disclosure on file
Abigail Elizabeth Connor Ms. Connor has nothing to disclose.
Alvand Moini Mr. Moini has nothing to disclose.
Paola Martinez, MD Dr. Martinez has nothing to disclose.
Deborah L. Carver, MD Dr. Carver has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan.
Blair Ford, MD, FAAN No disclosure on file
Richard Isacc Suarez Mr. Suarez has nothing to disclose.
Jenny Fortun, PhD Dr. Fortun has nothing to disclose.
Sheryl R. Haut, MD Dr. Haut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nile AI. Dr. Haut has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ventus. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVe.
Brian Edward Emmert, Jr., MD Dr. Emmert has nothing to disclose.
Grace Chen Kimbaris, MD Dr. Kimbaris has nothing to disclose.
Melissa Motta, MD, MPH Dr. Motta has nothing to disclose.
Ediel Almeida Mr. Almeida has nothing to disclose.
Nicholas Fioravante, MD Dr. Fioravante has nothing to disclose.
Kent Martine Mok Mr. Mok has nothing to disclose.
Megan E. Esch, MD Dr. Esch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Esch has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Esch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Esch has received research support from PCORI.
Patrick Joseph Callaghan Mr. Callaghan has nothing to disclose.
Neil R. Holland, MBBS, FAAN Dr. Holland has nothing to disclose.
Maryann Mays, MD, FAAN Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mays has received research support from Amgen.
Maya Mounir Ramy, MD Miss Ramy has nothing to disclose.
Tanu Garg, MD Dr. Garg has nothing to disclose.
Ryan Dinh Nguyen, MD Dr. Nguyen has nothing to disclose.
Tracey A. Milligan, MD, FAAN Dr. Milligan has nothing to disclose.
Ahamed Subir Humyum Kabir Mr. Kabir has nothing to disclose.
Ian Ramsay Mr. Ramsay has nothing to disclose.
Tiffany Alyssa Eatz Ms. Eatz has nothing to disclose.
Maxon Knott, Other The institution of Mr. Knott has received research support from American Heart Association.
Venkata Sai Manikant Sanikommu, MBBS Dr. Sanikommu has nothing to disclose.
Hayes Fountain An immediate family member of Mr. Fountain has received personal compensation for serving as an employee of Acumen Pharmaceuticals. An immediate family member of Mr. Fountain has received personal compensation for serving as an employee of Hexokine Therapeutics. An immediate family member of Mr. Fountain has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Acumen Pharmaceuticals. An immediate family member of Mr. Fountain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Hexokine Therapeutics. An immediate family member of Mr. Fountain has stock in Hexokine Therapeutics. An immediate family member of Mr. Fountain has stock in Acumen Pharmaceuticals.
Ahmed Abdelsalam, MD Dr. Abdelsalam has nothing to disclose.
Eva Wu, MD Dr. Wu has nothing to disclose.
Robert M Starke Robert M Starke has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Robert M Starke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Penumbra. The institution of Robert M Starke has received research support from NIH.
Dileep R. Yavagal, MD, FAAN Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Jeffrey Palmer No disclosure on file
Lorena Maria Figueredo Rivas, MD Dr. Figueredo Rivas has nothing to disclose.
Leonid Gozman, MD Dr. Gozman has nothing to disclose.
Michael P Siegel, MD Dr. Siegel has nothing to disclose.
Steven Carter Dr. Carter has nothing to disclose.
Lindsey Le, DO Dr. Le has nothing to disclose.
Maria J. Bruzzone, MD Dr. Bruzzone has nothing to disclose.
Jeffrey S. Gitt, DO No disclosure on file
Jonathan Williams, MD Dr. Williams has nothing to disclose.
Ventaka Bendi, MBBS Dr. Bendi has nothing to disclose.
David Heron, MD Dr. Heron has nothing to disclose.
Rachel Joyce Miller, MD Dr. Miller has nothing to disclose.
Adam Seth Greenblatt, MD Dr. Greenblatt has nothing to disclose.
Fabio Nascimento, MD Dr. Nascimento has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. The institution of Dr. Nascimento has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Nascimento has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Nascimento has received publishing royalties from a publication relating to health care. Dr. Nascimento has a non-compensated relationship as a Editorial Team Member with Neurology RFS that is relevant to AAN interests or activities. Dr. Nascimento has a non-compensated relationship as a Production Team with Neurology Podcast that is relevant to AAN interests or activities.
Julio Manuel Cuevas Mr. Cuevas has nothing to disclose.
Jens Watzlawik No disclosure on file
Ruta Nandan Yardi, MD Dr. Yardi has nothing to disclose.
Sally Valentina Mathias, MD, FANA, FAES Dr. Mathias has nothing to disclose.
Ana Maria Roman, MD Dr. Roman has nothing to disclose.
Christopher McLouth, PhD Dr. McLouth has nothing to disclose.
Lara Jehi, MD Dr. Jehi has nothing to disclose.
Rani Priyanka Vasireddy, MBBS Dr. Vasireddy has nothing to disclose.
Meghan Painter No disclosure on file
Andrew James Wood Mr. Wood has nothing to disclose.
Sandeepa Mullady, MD Dr. Mullady has nothing to disclose.
Elan Guterman, MD Dr. Guterman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Guterman has stock in REMO Health. The institution of Dr. Guterman has received research support from NIH. The institution of Dr. Guterman has received research support from AAN.
Nicole Rosendale, MD Dr. Rosendale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. The institution of Dr. Rosendale has received research support from American Academy of Neurology. The institution of Dr. Rosendale has received research support from NIH StrokeNet Fellowship. Dr. Rosendale has received publishing royalties from a publication relating to health care.
Louisa Papke No disclosure on file
Mohammad Dastjerdi, MD Dr. Dastjerdi has nothing to disclose.
Cindy McKernan, RN Mrs. McKernan has nothing to disclose.
Rachel Sora Kim No disclosure on file
Robert Kahoud No disclosure on file
Paneeni Lohana, DO Dr. Lohana has nothing to disclose.
Heidi Munger Clary, MD, MPH The institution of Dr. Munger Clary has received research support from National Institute of Health. The institution of Dr. Munger Clary has received research support from Suzanne Marcus Collins Foundation. The institution of Dr. Munger Clary has received research support from Eysz, Inc. Dr. Munger Clary has received personal compensation in the range of $500-$4,999 for serving as a speaker with American Epilepsy Society. Dr. Munger Clary has received personal compensation in the range of $0-$499 for serving as a Speaker with J. Kiffin Penry Epilepsy Education Programs. Dr. Munger Clary has a non-compensated relationship as a Chair, Psychosocial Comorbidities Committee with American Epilepsy Society that is relevant to AAN interests or activities.
Beverly M. Snively The institution of Beverly M. Snively has received research support from National Institutes of Health. The institution of Beverly M. Snively has received research support from Department of Defense. The institution of Beverly M. Snively has received research support from Duke Endowment.
Jerryl Christopher Mr. Christopher has nothing to disclose.
Sabina Gesell The institution of Sabina Gesell has received research support from PCORI. The institution of Sabina Gesell has received research support from The Duke Endowment. The institution of Sabina Gesell has received research support from NIH/NCATS. The institution of Sabina Gesell has received research support from NIH/NCI. The institution of Sabina Gesell has received research support from The Colorado Health Foundation. The institution of Sabina Gesell has received research support from The Clinton Foundation.
William Carey No disclosure on file
Mu Cheng, Other Ms. Cheng has received personal compensation for serving as an employee of Analysis Group, Inc..
Andra-Ecaterina Boca Miss Boca has received personal compensation for serving as an employee of Analysis Group, Inc.. The institution of Miss Boca has received research support from Acadia Pharmaceuticals Inc.
Ann Marie Dandurand, MD Dr. Dandurand has received personal compensation for serving as an employee of Cerevel. Dr. Dandurand has received personal compensation for serving as an employee of Otsuka. Dr. Dandurand has stock in Cerevel Therapeutics. An immediate family member of Dr. Dandurand has stock in Velocit . An immediate family member of Dr. Dandurand has stock in Cerebus.
Jiainbin Mao, PhD Dr. Mao has received personal compensation for serving as an employee of Cerevel Threrapeutics. Dr. Mao has stock in Cerevel Threrapeutics.
Koji Takahashi, PhD Dr. Takahashi has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Takahashi has stock in Cerevel Therapeutics.
Churong Xu Miss Xu has received personal compensation for serving as an employee of Analysis Group, Inc..
Yan Song, PhD Mr. Song has received personal compensation for serving as an employee of Analysis Group .
Moses Rodriguez, MD, FAAN Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Niels Victor Pacheco, MD Mr. Pacheco has nothing to disclose.
Carlos Alva-Diaz Carlos Alva-Diaz has nothing to disclose.
Andre Lapeyre Rivera Mr. Lapeyre Rivera has nothing to disclose.
Luis Fernando Purisaca Neira, MD Dr. Purisaca Neira has nothing to disclose.
Daniel Fernandez-Guzman, Jr., MD Mr. Fernandez-Guzman has nothing to disclose.
Poul Espino-Alvarado, MD Dr. Espino-Alvarado has nothing to disclose.
John Rolston Dr. Rolston has nothing to disclose.
Jorge G. Burneo, MD, MSPH, FAAN Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japanese Tobacco. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurinia Pharmaceuticals. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Oxford Health Policy Forum. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peervoice. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bristows .
Marissa Kellogg, MD, MPH Dr. Kellogg has nothing to disclose.
Megan Amuan Megan Amuan has nothing to disclose.
Jacqueline Hirschey, MD Dr. Hirschey has nothing to disclose.
W. Curt LaFrance, Jr., MD, MPH, FAAN Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care.
Hamada Hamid Altalib, DO The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from Eisai. The institution of Dr. Altalib has received research support from Sunovian. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
Rizwana Rehman Rizwana Rehman has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Veterans Health Administration.
Mary Jo Pugh, PhD, RN, FAAN The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs. The institution of Dr. Pugh has received research support from Sanofi.
David H. Margolin, MD,PhD Dr. Margolin has received personal compensation for serving as an employee of Cerevance, Inc. Dr. Margolin has received personal compensation in the range of $0-$499 for serving as a Consultant for Datacubed Health. Dr. Margolin has received stock or an ownership interest from Cerevance, Inc. Dr. Margolin has received stock or an ownership interest from Datacubed Health. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Drishti Shah, PhD Dr. Shah has received personal compensation for serving as an employee of Takeda.
Jeffrey Scott Andrews, Other Dr. Andrews has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Andrews has stock in Takeda Pharmaceuticals.
Arturo I. Benitez, MD Dr. Benitez has received personal compensation for serving as an employee of Takeda.
Jonathan de Courcy Jonathan de Courcy has nothing to disclose.
Yasmin Taylor, Other Miss Taylor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adelphi Real World.
Hannah Connolly, Other Miss Connolly has received personal compensation for serving as an employee of Adelphi Real World.
Sophie Alexandra Lai Miss Lai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adelphi Real World.
Vicente Villanueva Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW pharmaceutical. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW pharma. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle.
Paige Skorseth, MD Dr. Skorseth has nothing to disclose.
Rachael Eby, DO Dr. Eby has nothing to disclose.
Herbert Joseph No disclosure on file
Lucretia Long, CNP Mrs. Long has received personal compensation for serving as an employee of SKLife. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SKLife. Mrs. Long has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Sarita V. Maturu, MD Dr. Maturu has nothing to disclose.
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Edward B. Lee Pan, MD Dr. Lee Pan has nothing to disclose.
Lawrence Tucker, PhD, MBBS No disclosure on file
Shigeru Kaneki Mr. Kaneki has nothing to disclose.
Manisha Gupte Holmes, MD Dr. Holmes has nothing to disclose.
Sarah Barnard Sarah Barnard has nothing to disclose.
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Daniel H. Lowenstein, MD Dr. Lowenstein has received research support from NIH.
Kwee Liu Lin Thio, MD The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epilepsy Study Consortium. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ovid Therapeutics. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Biopharmaceuticals. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Thio has received research support from NIH. The institution of Dr. Thio has received research support from Siteman Cancer Center - Washington University, Barnes-Jewish Hospital. The institution of Dr. Thio has received research support from Epilepsy Study Consortium. The institution of Dr. Thio has received research support from St. Louis Children's Hospital Foundation. Dr. Thio has received intellectual property interests from a discovery or technology relating to health care.
Ruben I. Kuzniecky, MD, FAAN Dr. Kuzniecky has nothing to disclose.
Ahmed Moh'd Yassin, MD Dr. Yassin has nothing to disclose.
Ethar Hazaimeh, MD Dr. Hazaimeh has nothing to disclose.
Zaid Sofyan Saleh Miqdadi Mr. Miqdadi has nothing to disclose.
Sebawe Syaj, MD Dr. Syaj has nothing to disclose.
Salma Yahya Bashayreh, MD Dr. Bashayreh has nothing to disclose.
Khalid El-Salim No disclosure on file
Yasmeen Jamal Al-abdallat, MD Miss Al-abdallat has nothing to disclose.
Abdallah Issam Mahmoud AlHusan Mr. AlHusan has nothing to disclose.
Maria Claudia Burbano, MD Dr. Burbano has nothing to disclose.
Lucia Belen Varela Miss Varela has nothing to disclose.
Carlos Andres Mateos, MD Mrs. Mateos has nothing to disclose.
Yandri Lorena Garcia Fernandez, MD Dr. Garcia Fernandez has nothing to disclose.
Francisco Abril, MD Dr. Abril has nothing to disclose.
Juan Carlos Avalos, MD Dr. Avalos has nothing to disclose.
Gabriela Besocke Gabriela Besocke has nothing to disclose.
Barbara *use 150531 Rosso, MD Dr. Rosso has nothing to disclose.
Walter H. Silva No disclosure on file
Silvia Christiansen Silvia Christiansen has nothing to disclose.
Carlos Alberto Ciraolo, Sr., PhD Mr. Ciraolo has nothing to disclose.
Maria del Carmen Garcia, 11363 Maria del Carmen Garcia, 11363 has nothing to disclose.
Necdet Sut No disclosure on file
Mario Minor Murakami, Jr., MD Dr. Murakami has nothing to disclose.
Carl Trolle, MD Mr. Trolle has stock in Diamyd Medical.
Diana Tran, Other Miss Tran has nothing to disclose.
Brit Seipp Ms. Seipp has nothing to disclose.
Clas Linnman, PhD The institution of Prof. Linnman has received research support from Wings For Life. The institution of Prof. Linnman has received research support from Promobilia Foundation. The institution of Prof. Linnman has received research support from NIH.
Nguyen Nguyen Mr. Nguyen has nothing to disclose.
Ricardo Battaglino, PhD Dr. Battaglino has nothing to disclose.
Leslie Morse, DO Dr. Morse has nothing to disclose.
Umang M. Shah, MD No disclosure on file
Alyssa Nylander, MD, PhD Dr. Nylander has nothing to disclose.
Kyra Henderson Miss Henderson has nothing to disclose.
Kanishka Koshal, Other Ms. Koshal has nothing to disclose.
Nikki Sisodia Ms. Sisodia has nothing to disclose.
Shane Poole Mr. Poole has nothing to disclose.
Jim Rowson, PhD Mr. Rowson has received personal compensation for serving as an employee of Google.
Cathra Halabi, MD The institution of Dr. Halabi has received research support from Pac12 Student Health and Wellbeing Initiative. The institution of Dr. Halabi has received research support from UC Noyce Initiative. The institution of Dr. Halabi has received research support from Weill Institute for Neurosciences Neurohub.
Jill L. Ostrem, MD, FAAN Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Ostrem has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superness. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcureX. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Ostrem has received research support from Neuroderm. The institution of Dr. Ostrem has received research support from Boston Scientific. The institution of Dr. Ostrem has received research support from Medtronic. The institution of Dr. Ostrem has received research support from Rune.
Simon Little, MBBS,PhD Dr. Little has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. The institution of Dr. Little has received research support from NIH. The institution of Dr. Little has received research support from RuneLabs. The institution of Dr. Little has received research support from DMRF. The institution of Dr. Little has received research support from DARPA.
Ethan G. Brown, MD Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Adam Staffaroni Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly/Prevail. The institution of Adam Staffaroni has received research support from Larry L. Hillblom Foundation. The institution of Adam Staffaroni has received research support from NIA/NIH. The institution of Adam Staffaroni has received research support from Bluefield Project to Cure FTD. Adam Staffaroni has received personal compensation in the range of $0-$499 for serving as a Scientific Review Board with Alzheimer's Drug Discovery Foundation. Adam Staffaroni has received personal compensation in the range of $0-$499 for serving as a Inventor/Holder of Task License with Datacubed Health.
Yuriy Zeylikman, MD No disclosure on file
Shaumprovo Debnath, Other Mr. Debnath has nothing to disclose.
Umer Akbar, MD Dr. Akbar has nothing to disclose.
Austin Flitton Mr. Flitton has nothing to disclose.
Michael Ferguson, PhD Dr. Ferguson has nothing to disclose.
Jared A Nielsen, PhD Prof. Nielsen has nothing to disclose.
Frederic Schaper, MD, PhD Dr. Schaper has nothing to disclose.
Elijah Baughan, Other Mr. Baughan has nothing to disclose.
Evren Burakgazi, MD Dr. Burakgazi has nothing to disclose.
Ram Kinker Mishra, PhD Dr. Mishra has received personal compensation for serving as an employee of Biosensics.
Mansi Sharma Miss Sharma has nothing to disclose.
Jose Casado Mr. Casado has received personal compensation for serving as an employee of BioSensics LLC.
Adonay Nunes, PhD Dr. Nunes has received personal compensation for serving as an employee of Biosensics.
Ashkan Vaziri, PhD Dr. Vaziri has received personal compensation for serving as an employee of Biosensics.
Alexander Pantelyat, MD, FAAN Dr. Pantelyat has received personal compensation for serving as an employee of MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelly & Ignoffo Law Group. The institution of Dr. Pantelyat has received research support from NIH/NIA.
Anne Marie A. Wills, MD Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant, a CVS/Caremark company. Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi/Genzyme. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Wills has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Wills has received research support from Parkinson's Foundation. The institution of Dr. Wills has received research support from Biogen. The institution of Dr. Wills has received research support from Roche/Genentech. The institution of Dr. Wills has received research support from BioSensics.
AJ Jane Hall Ms. Hall has received research support from National Institutes of Health.
Melissa Ann Carran, MD No disclosure on file
Raphael Bertani, MD Dr. Bertani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brain4care .
Savio Batista Mr. Batista has nothing to disclose.
Leonardo De Barros Oliveira Mr. Oliveira has nothing to disclose.
Lucca Biolcati Palavani, Sr., MD Mr. Palavani has nothing to disclose.
Marcelo E. Bigal, MD, PhD No disclosure on file
David Young Chung, MD Dr. Chung has received research support from NIH/NINDS. Dr. Chung has received research support from The Aneurysm and AVM Foundation.
Cenk Ayata, MD Dr. Ayata has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quris. Dr. Ayata has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Ayata has received research support from NIH. The institution of Dr. Ayata has received research support from Takeda. The institution of Dr. Ayata has received research support from Neurelis.
Brian Edlow, MD Dr. Edlow has received research support from NIH.
Miran Oncel Mr. Oncel has nothing to disclose.
James Han Lai Mr. Lai has nothing to disclose.
Jian Li Dr. Li has nothing to disclose.
Sanem A. Aykan, MD,PhD Dr. Aykan has nothing to disclose.
Andrea Harriott, MD Dr. Harriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to AAN interests or activities. Dr. Harriott has a non-compensated relationship as a Researcher/Receipt of drug with Praxis that is relevant to AAN interests or activities.
David Alan Boas, PhD Prof. Boas has received personal compensation for serving as an employee of Boston University. An immediate family member of Prof. Boas has received personal compensation for serving as an employee of Massachusetts General Hospital. The institution of Prof. Boas has received research support from NIH.
Joanna Yang Miss Yang has nothing to disclose.
Sava Sakadzic, PhD The institution of Dr. Sakadzic has received research support from National Institute of Health.
Tao Qin Tao Qin has received personal compensation for serving as an employee of Helix Nanotechnologies.
Abbas Alibhoy No disclosure on file
Mazzy Frost Marcucci Ms. Marcucci has nothing to disclose.
Keaton Charles Helquist, Other Mr. Helquist has nothing to disclose.
Owen Benzley Mr. Benzley has nothing to disclose.
Michele D. Bronson, PhD No disclosure on file
Saurabh Garg, Other Mr. Garg has received personal compensation for serving as an employee of Prenuvo.
Sam Hashemi Mr. Hashemi has received personal compensation for serving as an employee of Prenuvo.
Raj Attariwala, MD,PhD Dr. Attariwala has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Prenuvo. Dr. Attariwala has stock in Prenuvo. Dr. Attariwala has received research support from Voxelwise Imaging Technology. Dr. Attariwala has received personal compensation in the range of $100,000-$499,999 for serving as a Radiologist reading cases and helping build in house software tools with Prenuvo.
Nasrin Akbari, Other Ms. Akbari has received personal compensation for serving as an employee of VoxelWise Imaging Technology Inc.
Madhurima Datta, PhD Dr. Datta has received personal compensation for serving as an employee of Prenuvo.
Soojin Lee, PhD Dr. Lee has received personal compensation for serving as an employee of Prenuvo. Dr. Lee has received personal compensation for serving as an employee of University of British Columbia.
Thanh Duc Nguyen, Sr., PhD Dr. Nguyen has nothing to disclose.
Arun Rajendran, Other Mr. Rajendran has received personal compensation for serving as an employee of Prenuvo. Mr. Rajendran has received personal compensation for serving as an employee of SoundHound. Mr. Rajendran has received personal compensation for serving as an employee of Xtract AI.
Yosef Chodakiewitz, MD Dr. Chodakiewitz has received personal compensation for serving as an employee of Prenuvo . Dr. Chodakiewitz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aidoc.
No disclosure on file
Jorge Cervantes Mr. Cervantes has nothing to disclose.
Shirin Jamal Omidi, MD Dr. Jamal Omidi has nothing to disclose.
Rodrigo Hasbun Rodrigo Hasbun, 3584 has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biofire. Rodrigo Hasbun, 3584 has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biofire. The institution of Rodrigo Hasbun, 3584 has received research support from Biofire. Rodrigo Hasbun, 3584 has received publishing royalties from a publication relating to health care.
Rajesh K. Gupta, MBBS Dr. Gupta has nothing to disclose.
Rafael Escandon No disclosure on file
Ana Morales Ana Morales has received personal compensation for serving as an employee of Invitae. Ana Morales has stock in Invitae.
John Garcia, PhD Dr. Garcia has received personal compensation for serving as an employee of Invitae.
Tali Ekstein, Other Mrs. Ekstein has received personal compensation for serving as an employee of Invitae. Mrs. Ekstein has stock in Invitae.
Catherine Schlechter, Other Mrs. Schlechter has received personal compensation for serving as an employee of Invitae. Mrs. Schlechter has stock in Invitae.
Jasmine Patanapirom, Other Miss Patanapirom has nothing to disclose.
Tanya Bardakjian Tanya Bardakjian has received personal compensation for serving as an employee of sarepta Therapeutics. Tanya Bardakjian has stock in Sarepta.
Erin O'Rourke Erin O'Rourke has received personal compensation for serving as an employee of Sarepta Therapeutics. Erin O'Rourke has stock in Sarepta Therapeutics.
Andrew Yuri Robinson, MD No disclosure on file
Yunting Yu Miss Yu has nothing to disclose.
Nader S. Dahdaleh, MD Dr. Dahdaleh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Depuy Spine.
Sachin Govind Mr. Govind has nothing to disclose.
Patrick M. Grogan, MD, FAAN No disclosure on file
Lincey Alexida Wilson, MD Dr. Wilson has nothing to disclose.
Jacob D. Ralston Mr. Ralston has nothing to disclose.
Anna Lucia Zukowski Miss Zukowski has nothing to disclose.
Duaa Dakhlallah, PhD Dr. Dakhlallah has nothing to disclose.
Kate Karelina, PhD Dr. Karelina has received research support from NIGMS.
James Simpkins James Simpkins has nothing to disclose.
Muhammad M. Alvi, MD, FAAN Dr. Alvi has nothing to disclose.
Candice Brown, PhD The institution of Dr. Brown has received research support from Helen Lewis Foundation. The institution of Dr. Brown has received research support from National Institutes of Health.
Pedro Lylyk, MD Prof. Lylyk has nothing to disclose.
Adnan H. Siddiqui Adnan H. Siddiqui has received personal compensation for serving as an employee of The Jacobs Institute. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Amnis Therapeutics. Adnan H. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Apellis Pharmaceuticals, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canon Medical Systems USA, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Cardinal Health 200, LLC. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebrotech Medical Systems, Inc.,. Adnan H. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerenovus. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerevatech Medical, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cordis. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Corindus, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Endostream Medical, Ltd. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Integra. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for IRRAS AB. Adnan H. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Adnan H. Siddiqui has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MicroVention. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Minnetronix Neuro, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Penumbra. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Q'Apel Medical, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Rapid Medical. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Serenity Medical, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Silk Road Medical. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for StimMed, LLC. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker Neurovascular. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Three Rivers Medical, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for VasSol. Adnan H. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Viz.ai, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for W.L. Gore & Associates. Adnan H. Siddiqui has stock in Adona Medical, Inc.. Adnan H. Siddiqui has stock in Amnis Therapeutics. Adnan H. Siddiqui has stock in Bend IT Technologies. Adnan H. Siddiqui has stock in BlinkTBI, Inc. Adnan H. Siddiqui has stock in Cerebrotech Medical Systems, Inc. Adnan H. Siddiqui has stock in Cerevatech Medical, Inc.. Adnan H. Siddiqui has stock in Cognition Medical. Adnan H. Siddiqui has stock in CVAID Ltd.. Adnan H. Siddiqui has stock in E8, Inc.. Adnan H. Siddiqui has stock in Endostream Medical, Ltd. Adnan H. Siddiqui has stock in Imperative Care, Inc.. Adnan H. Siddiqui has stock in Instylla, Inc.. Adnan H. Siddiqui has stock in Launch NY, Inc.. Adnan H. Siddiqui has stock in NeuroRadial Technologies, Inc.. Adnan H. Siddiqui has stock in Neurovascular Diagnostics, Inc.. Adnan H. Siddiqui has stock in PerFlow Medical, Ltd.. Adnan H. Siddiqui has stock in Q'Apel Medical, Inc.. Adnan H. Siddiqui has stock in QAS.ai, Inc.. Adnan H. Siddiqui has stock in Radical Catheter Technologies, Inc.. Adnan H. Siddiqui has stock in Rebound Therapeutics Corp. (Purchased 2019 by Integra Lifesciences, Corp). Adnan H. Siddiqui has stock in Rist Neurovascular, Inc, (Purchased 2020 by Medtronic). Adnan H. Siddiqui has stock in Sense Diagnostics, Inc.. Adnan H. Siddiqui has stock in Serenity Medical, Inc.. Adnan H. Siddiqui has stock in Silk Road Medical. Adnan H. Siddiqui has stock in SongBird Therapy. Adnan H. Siddiqui has stock in Spinnaker Medical, Inc.. Adnan H. Siddiqui has stock in StimMed, LLC. Adnan H. Siddiqui has stock in Synchron, Inc.. Adnan H. Siddiqui has stock in Three Rivers Medical, Inc.. Adnan H. Siddiqui has stock in Truvic Medical, Inc.. Adnan H. Siddiqui has stock in Tulavi Therapeutics, Inc.. Adnan H. Siddiqui has stock in Vastrax, LLC. Adnan H. Siddiqui has stock in VICIS, Inc.. Adnan H. Siddiqui has stock in Viseon, Inc.. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a National PI/Steering Committees: EXCELLENT and ARISE II Trial with Cerenovus. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a National PI/Steering Committees: SWIFT PRIME, VANTAGE, EMBOLISE and SWIFT DIRECT Trials with Medtronic. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a National PI/Steering Committees: FRED Trial & CONFIDENCE Study with MicroVention. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a National PI/Steering Committees: 3D Separator Trial, COMPASS Trial, INVEST Trial with Penumbra. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a National PI/Steering Committees: EVAQ Trial with MIVI neuroscience. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a National PI/Steering Committee: SUCCESS Trial with Rapid Medical. Adnan H. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as a Steering Committee for C GUARDIANS IDE Pivotal Tria with InspireMD.
Howard Riina Howard Riina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic . Howard Riina has stock in eVasc Neuro. Howard Riina has received intellectual property interests from a discovery or technology relating to health care.
Ivan Lylyk, MD Dr. Lylyk has nothing to disclose.
Carlos Daniel Bleise, Sr., MD Dr. Bleise has nothing to disclose.
Esteban Scrivano, MD Dr. Scrivano has nothing to disclose.
Pedro Nicolas Lylyk Mr. Lylyk has nothing to disclose.
Joseph Antonios Dr. Antonios has nothing to disclose.
Brandon Beneduce Mr. Beneduce has received personal compensation for serving as an employee of CereVasc. Mr. Beneduce has stock in CereVasc.
Elad I. Levy No disclosure on file
Carl Heilman, MD Dr. Heilman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cerevasc Inc. Dr. Heilman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurosurgery. Dr. Heilman has stock in Cerevasc, Inc. Dr. Heilman has received intellectual property interests from a discovery or technology relating to health care.
Adel Malek, MD, PhD Prof. Malek has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for CereVasc Inc.. Prof. Malek has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerus Endovascular/Stryker. Prof. Malek has stock in CereVasc Inc.. Prof. Malek has received intellectual property interests from a discovery or technology relating to health care.
Jenny Peih-Chir Tsai, MD No disclosure on file
Sanjula Dhillon Singh, MD, PhD Dr. Singh has nothing to disclose.
Cyprien Rivier, MD Dr. Rivier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyxis Partners.
Tin Oreskovic Mr. Oreskovic has nothing to disclose.
Sinclair Carr Mr. Carr has nothing to disclose.
Keren Papier, Other Dr. Papier has nothing to disclose.
Zeina N. Chemali, MD Dr. Chemali has nothing to disclose.
Leidys Gutierrez-Martinez, MD The institution of Dr. Gutierrez-Martinez has received research support from American Heart Association.
Akashleena Mallick, MD, MBBS Dr. Mallick has nothing to disclose.
Livia Parodi, PhD Dr. Parodi has nothing to disclose.
Ernst Mayerhofer, MD Dr. Mayerhofer has nothing to disclose.
Jasper R. Senff, MD Dr. Senff has nothing to disclose.
Christina Kourkoulis Christina Kourkoulis has nothing to disclose.
Sandro Marini, MD No disclosure on file
Santiago Clocchiatti-Tuozzo Mr. Clocchiatti-Tuozzo has nothing to disclose.
Courtney Nunley No disclosure on file
Amy L. Newhouse, MD Dr. Newhouse has nothing to disclose.
An Ouyang No disclosure on file
Ronald M. Lazar, PhD, FAHA, FAAN Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Aleksandra Pikula, MD The institution of Dr. Pikula has received research support from CIHR.
Sarah Ibrahim Sarah Ibrahim has nothing to disclose.
Bart Brouwers, PhD,MD Dr. Brouwers has nothing to disclose.
Virginia J. Howard, PhD The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
George Howard, PhD Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Nirupama Yechoor, MD Dr. Yechoor has nothing to disclose.
Cornelia Van Duijn Prof. Van Duijn has nothing to disclose.
Thomas Littlejohns Dr. Littlejohns has nothing to disclose.
Jonathan Rosand, MD Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rosand has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for National Football League. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Gregory Fricchione, MD Dr. Fricchione has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Belvoir Publishing. Dr. Fricchione has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Publishing. Dr. Fricchione has stock in Revival Therapeutics. The institution of Dr. Fricchione has received research support from NIMH. Dr. Fricchione has received intellectual property interests from a discovery or technology relating to health care. Dr. Fricchione has received publishing royalties from a publication relating to health care. Dr. Fricchione has received publishing royalties from a publication relating to health care. Dr. Fricchione has received publishing royalties from a publication relating to health care.
Christopher D. Anderson, MD,PhD, FAAN The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
Guido Jose Falcone, MD The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Mark Kinach No disclosure on file
Megan Conroy Mrs. Conroy has received research support from UK Biobank.
Tim Patterson No disclosure on file
Naga Vijaya Lakshmi Boorle, MBBS Dr. Boorle has nothing to disclose.
Nithin C. Kurra, MBBS, MPH Dr. Kurra has nothing to disclose.
Nikhila Gandrakota, MD Dr. Gandrakota has nothing to disclose.
Karnav Modi, MD Dr. Modi has nothing to disclose.
Kavya Sudireddy, MBBS Dr. Sudireddy has nothing to disclose.
Shayan Ali Irfan, MBBS Dr. Irfan has nothing to disclose.
Akhil Jain, MD Dr. Jain has nothing to disclose.
Priyanka Parikh, MBBS Mrs. Parikh has nothing to disclose.
Dinesh V. Jillella, MD Dr. Jillella has nothing to disclose.
Morris Freedman, MD, FAAN No disclosure on file
Toka Samy Elboraay Ms. Elboraay has nothing to disclose.
Hadeer Elsaeed AboElfarh, MD Dr. AboElfarh has nothing to disclose.
Mohamed Mahmoud Fathy Elmallahy, MD Dr. Elmallahy has nothing to disclose.
Lena Said Mansour, MBBS Dr. Mansour has nothing to disclose.
Heba Ahmed Elsayed Aboeldahab, Other Dr. Aboeldahab has nothing to disclose.
Ahmed Abd Eltawab, MD Dr. Abd Eltawab has nothing to disclose.
Rehab Adel Diab, II Dr. Diab has nothing to disclose.
Mahmoud Ahmed Ebada Mr. Ebada has nothing to disclose.
Shrouk Fawze Mohamed Dr. Mohamed has nothing to disclose.
Mohammed Ilyas, MD Dr. Ilyas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix Professional Advisory Board.
Eric *Use 332463 Dunn, DO Dr. Dunn has nothing to disclose.
Aarushi Suneja, MD Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Mitchel Todd Williams, MD No disclosure on file
Ashhar Ali, DO, FAAN Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Ahmed Abdelrahman Babiker Mohamedelkhair, MBBS Dr. Mohamedelkhair has nothing to disclose.
Abdelrahman Essam Ahmed Soliman Elfaham, MBBS Dr. Elfaham has nothing to disclose.
Ruth Gabizon No disclosure on file
Katherine Dorfman Ms. Dorfman has nothing to disclose.
Sara Zeccardi, NP Ms. Zeccardi has nothing to disclose.
Seniha N. Ozudogru, MD Dr. Ozudogru has nothing to disclose.
Michal Mizrahi No disclosure on file
Isaac Smith, DO, MS Dr. Smith has nothing to disclose.
Raissa Aoun, MD Dr. Aoun has nothing to disclose.
Rebecca Lalchan, DO Dr. Lalchan has nothing to disclose.
Yael Friedman-Levy No disclosure on file
Jose Francisco Ortega Tola, MD Dr. Ortega Tola has nothing to disclose.
Daniel Moreno-Zambrano, MD Dr. Moreno-Zambrano has nothing to disclose.
Farah A. Chohan, MD,MBBS Dr. Chohan has nothing to disclose.
Hector Lalama, MD Dr. Lalama has nothing to disclose.
Mohan C. Deochand, MD Dr. Deochand has nothing to disclose.
Liraz Larush No disclosure on file
Co Dinh Duong, MD Dr. Duong has nothing to disclose.
John Kyle Jenkins, MD Dr. Jenkins has nothing to disclose.
Danielle Wilhour, MD Dr. Wilhour has nothing to disclose.
Daniel R. Kramer Dr. Kramer has nothing to disclose.
Kati Frid No disclosure on file
Cristina Alejandra Cruz, MD Dr. Cruz has nothing to disclose.
Dayna Karim Rivera Miss Rivera has nothing to disclose.
Yadira Flores-Montanez, MD Dr. Flores-Montanez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Flores-Montanez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Rafael J. Lopez-Baquero, MD Dr. Lopez-Baquero has nothing to disclose.
Orli Binyamin No disclosure on file
Justin Nofar, MD Dr. Nofar has nothing to disclose.
Mina Sitto Miss Sitto has nothing to disclose.
Yamin Sallowm, MD Dr. Sallowm has nothing to disclose.
Nina Feinstein No disclosure on file
Sai Lavanya Patnala Ms. Patnala has nothing to disclose.
Anu Mohandas, MD,MBBS Dr. Mohandas has nothing to disclose.
Dvir Dori, MD No disclosure on file
Andres Inzunza, MD Dr. Inzunza has nothing to disclose.
Victor Garcia Navarro, MD Mr. GARCIA NAVARRO has nothing to disclose.
Gabriela Petersen, MD Dr. Petersen has nothing to disclose.
Alexandra Diaz Alba Alexandra Diaz Alba has nothing to disclose.
Daniela Nieto, MD Dr. Nieto has nothing to disclose.
Karla Madrigal, MD Dr. Madrigal has nothing to disclose.
Anabell Ascencio, MD No disclosure on file
Eduardo Martin-Nares, MD Dr. Martin-Nares has nothing to disclose.
Edna Amaya, MD Dr. Amaya has nothing to disclose.
Jorge Paz Gutierrez No disclosure on file
Manuel Solano, MD Dr. Solano has nothing to disclose.
Cindy Joseph, MD No disclosure on file
Bahadar Singh Srichawla, DO, MS Dr. Srichawla has nothing to disclose.
Muhammad Romail Manan, MBBS Dr. Manan has nothing to disclose.
Vincent Kipkorir Dr. Kipkorir has nothing to disclose.
ARKADEEP DHALI, MBBS Dr. DHALI has nothing to disclose.
Tirtha Sawant Ms. Sawant has nothing to disclose.
Subtain Zia, DO Dr. Zia has nothing to disclose.
Diego Carrion-Alvarez No disclosure on file
Richard Suteja No disclosure on file
Khulud Nurani No disclosure on file
Mihnea Gaman, MD Dr. Gaman has nothing to disclose.
Sebastian Diebel, MD,PT Dr. Diebel has nothing to disclose.
Jacob S. Elkins, MD No disclosure on file
Jeffrey Chen, MD Dr. Chen has nothing to disclose.
Charanpreet Padam, MD, MBBS Charanpreet Padam has nothing to disclose.
Justine E. Cormier, MD Dr. Cormier has nothing to disclose.
Vladislav Zayas, MD Dr. Zayas has nothing to disclose.
Paul Anthony, MD Mr. Anthony has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Gilead Sciences.
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Amanda Rubin, DO Dr. Rubin has nothing to disclose.
Edward John Gettings, DO Dr. Gettings has nothing to disclose.
Arianna Giebink, MD Dr. Giebink has nothing to disclose.
Manjit McNeill Manjit McNeill has nothing to disclose.
Paul Partyka, DO, PhD Dr. Partyka has nothing to disclose.
Rajesh Burela, DO Mr. Burela has nothing to disclose.
Hope Ajom Okpokam, MD Dr. Okpokam has nothing to disclose.
Daniel E. Kaufman Mr. Kaufman has nothing to disclose.
Sumera Javed, MD,MBBS Miss Javed has nothing to disclose.
Yakov Isakov, DO Dr. Isakov has nothing to disclose.
Alexandr L. Safarov, MD Dr. Safarov has nothing to disclose.
Paul Wright, MD, FAAN Dr. Wright has nothing to disclose.
Katherine A. Riester, MPH No disclosure on file
DaYoung Kim, DO Dr. Kim has nothing to disclose.
Xu Tang, DO Dr. Tang has nothing to disclose.
Ian Rankine, DO Ian Rankine has nothing to disclose.
Amanda Brodeur, DO Dr. Brodeur has nothing to disclose.
Frank Wang, DO Dr. Wang has nothing to disclose.
Sarah Shortall, Other Ms. Shortall has nothing to disclose.
Ernst-Wilhelm *167769 Radue, MD No disclosure on file
Danah Bakir, MD Dr. Bakir has nothing to disclose.
Abdullah Al Sawaf, MD Dr. Al Sawaf has nothing to disclose.
Hayrettin Tumani, MD Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Francesca Pastrana, MD Dr. Pastrana has nothing to disclose.
Hanan Qaqish, MD Dr. Qaqish has nothing to disclose.
Wilson Eduardo Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Adam Awad, MD Dr. Awad has nothing to disclose.
Momina Soudagar-Turkey, MD Dr. Soudagar-Turkey has nothing to disclose.
Subin Jang Ms. Jang has nothing to disclose.
Gavin DeFisser Mr. DeFisser has nothing to disclose.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ziemssen has received research support from Biogen. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from Celgene.
Margaret Marie Wilson-Murphy, MD Dr. Wilson-Murphy has nothing to disclose.
Rebecca MacRae, MD Dr. MacRae has nothing to disclose.
Celia Greenlaw, MD Dr. Greenlaw has nothing to disclose.
Jenifer Nicole Moceri, DO Dr. Moceri has nothing to disclose.
Krima Patel, DO Dr. Patel has nothing to disclose.
Cory P. Hackmyer, DO Dr. Hackmyer has nothing to disclose.
Jennifer Axelband, DO Dr. Axelband has nothing to disclose.
Martin Marziniak, PhD No disclosure on file
Sathvik S Shastry, MD Dr. Shastry has nothing to disclose.
Ajay Menon, MD Dr. Menon has nothing to disclose.
Aiman Sajjad, DO Dr. Sajjad has nothing to disclose.
Cleo Zarina Alejo Reyes, MD Dr. Reyes has nothing to disclose.
Gary W. Clauser, MD Dr. Clauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bigoen . The institution of Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech . Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genzyme. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartid.
Omotola A. Hope, MD Dr. Hope has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Donald Gilbert, MD, FAAN Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex. The institution of Dr. Gilbert has received research support from PTC Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Timothy Cunniff, PharmD Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Frederick E. Munschauer, III, MD, FAAN Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
George Karkanias, PhD Dr. Karkanias has received personal compensation for serving as an employee of Emalex Biosciences, Inc.
Sarah Diana Atkinson, MD Dr. Atkinson has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Atkinson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for World Wide Clinical Trials.
Stephen Wanaski, PhD Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences.
Nandhagopal Ramachandiran, MBBS, DM, FAAN, FRCP No disclosure on file
Sarah Grace Trulove, MBA Ms. Trulove has nothing to disclose.
Leon S. Dure, MD Dr. Dure has nothing to disclose.
Jan Rowe Dr. Rowe has received personal compensation in the range of $500-$4,999 for serving as a Developed training manual with Tourette Association of America .
Emily S. Gantz, DO Dr. Gantz has nothing to disclose.
Michael Schulzer No disclosure on file
Irene Malaty, MD, FAAN Dr. Malaty has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Neuroderm. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Cleveland Clinic. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Daniel Joseph Ibrahim Mr. Ibrahim has nothing to disclose.
Heather Simpson, Other Dr. Simpson has received personal compensation for serving as an employee of Tourette Association of America. Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tourette Association of America.
Joshua Wong, MD The institution of Dr. Wong has received research support from NIH.
Lisa Kuramoto No disclosure on file
Natalia Szejko, MD, PhD Dr. Szejko has nothing to disclose.
Davide Martino, MD, PhD Dr. Martino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Martino has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz Pharma Canada Ltd..
Julian Fletcher Julian Fletcher has received personal compensation in the range of $50,000-$99,999 for serving as a Program Coordinator with Tourette OCD Alberta Network.
Tamara M. Pringsheim, MD, FAAN The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Jacquelyn Cragg No disclosure on file
Phillip L. Pearl, MD, FAAN Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care.
Bruria Ben Zeev Prof. Ben Zeev has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC.
Daniel Curry, MD No disclosure on file
Scellig Stone, MD,PhD Dr. Stone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microbot Medical, Alcyone.
Matthew Vestal Dr. Vestal has nothing to disclose.
Rafael Sierra, PhD Dr. Sierra has received personal compensation for serving as an employee of PTC Therapeutics Inc. Dr. Sierra has stock in PTC Therapeutics Inc.
Vinay Penematsa Vinay Penematsa has nothing to disclose.
Antonia Wang, PhD Dr. Wang has received personal compensation for serving as an employee of PTC Therapeutics. Dr. Wang has received stock or an ownership interest from PTC Therapeutics, Inc..
Lee Golden Dr. Golden has received personal compensation for serving as an employee of PTC Therapeutics.
Paul Wuh-Liang Hwu Paul Wuh-Liang Hwu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics Inc.. Paul Wuh-Liang Hwu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. The institution of Paul Wuh-Liang Hwu has received research support from PTC therapeutics.
Vesna Sossi No disclosure on file
Tanishq Kesani Mr. Kesani has nothing to disclose.
Lakshmi Sai Deepak R Velugoti, MBBS Dr. Velugoti has nothing to disclose.
Shreya R. Kethiri Ms. Kethiri has nothing to disclose.
Dhanya Gorty Miss Gorty has nothing to disclose.
Raul De La Fuente-Fernandez, MD No disclosure on file
Cintia Margoth Armas-Puente Cintia Margoth Armas-Puente has nothing to disclose.
Carlos Cosentino, MD, FAAN Dr. Cosentino has nothing to disclose.
YESENIA NUNEZ CORONADO, MD Dr. NUNEZ CORONADO has nothing to disclose.
Marcela Alvarado Morales, Jr., NP Ms. Alvarado Morales has nothing to disclose.
Gabriela Gushiken, MD Dr. Gushiken has nothing to disclose.
MIRIAM VELEZ, MD MIRIAM VELEZ, MD has nothing to disclose.
Rafael Suarez Rafael Suarez has nothing to disclose.
Luis Eduardo Torres, Sr., MD Dr. Torres has nothing to disclose.
Danilo Americo Sanchez Coronel, Sr., MD Dr. Sanchez Coronel has nothing to disclose.
Hugo Enrique Estrada Vegas, MD Dr. ESTRADA VEGAS has nothing to disclose.
A Jon Stoessl, MD, FAAN No disclosure on file
Audrey Hunt, DO Dr. Hunt has nothing to disclose.
Lubna Jafri, MD, MBBS Dr. Jafri has nothing to disclose.
Jessica Tate, MD The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation.
Alexander Paciorkowski, MD The institution of Dr. Paciorkowski has received research support from University of Rochester.
Jaclyn Martindale, DO Dr. Martindale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Dr. Martindale has received research support from Tourette Association of America. The institution of Dr. Martindale has received research support from American Board of Neurology and Psychiatry.
Ginny Lane, MD Student Ginny Lane has nothing to disclose.
Lia Thibodaux, PhD Dr. Thibodaux has nothing to disclose.
Leah Chapman The institution of Dr. Chapman has received research support from NIH. The institution of Dr. Chapman has received research support from NIH.
Solene Moulin No disclosure on file
Prabhjot Kaur Miss Kaur has received research support from DST-INSPIRE.
Davinder Singh Dr. Singh has received personal compensation for serving as an employee of The Ohio State University. Dr. Singh has received research support from Indian Council of Medical Research.
NAKUL BHARDWAJ Mr. BHARDWAJ has received research support from UGC.
Neena Bedi, PhD The institution of Dr. Bedi has received research support from UGC.
Saroj Arora, PhD The institution of Prof. Arora has received research support from Government of Punjab.
Didier Leys, MD, FAAN The institution of Dr. Leys has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Leys has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Susanna Schraen-Maschke No disclosure on file
Wenzheng Yu, MD Dr. Yu has nothing to disclose.
Aya Naji Shnawa, MD Dr. Shnawa has nothing to disclose.
Jeffrey Swarz, MD No disclosure on file
Ambreen Fatima Zaidi Ms. Zaidi has nothing to disclose.
Lester Y. Leung, MD Dr. Leung has received research support from NIH.
Regis Bordet No disclosure on file
Michaela Pernon, PhD Dr. Pernon has received research support from UNADREO (PhD award). Dr. Pernon has received personal compensation in the range of $500-$4,999 for serving as a Expert with Ad Scientam. Dr. Pernon has received personal compensation in the range of $10,000-$49,999 for serving as a Trainer with Neuroformations.
Chloé Laurencin, MD,PhD Dr. Laurencin has nothing to disclose.
Grégoire Lafay, PhD Dr. Lafay has received personal compensation for serving as an employee of Ad Scientiam.
Arthur Feyt Mr. Feyt has received personal compensation for serving as an employee of Ad Scientiam.
Kenza Drareni, PhD Dr. Drareni has received personal compensation for serving as an employee of Ad scientiam.
Clémence Faulcon, Other Miss Faulcon has received personal compensation for serving as an employee of Ad Scientiam.
Emilie Guilpain, Other Dr. Guilpain has received personal compensation for serving as an employee of Ad Scientiam.
Aurelia Poujois No disclosure on file
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Lakshmi Priya, MD Dr. Priya has nothing to disclose.
Aya Mohamed Haggiagi, MD No disclosure on file
Katherine Longardner, MD Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Longardner has received research support from NIH.
Dietrich Haubenberger, MD, FAAN Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.
Yasoda Satpathy Ms. Satpathy has nothing to disclose.
Margaret Tugend Ms. Tugend has nothing to disclose.
Christina M. Ulane, MD, PhD Dr. Ulane has nothing to disclose.
Raymond Sekula No disclosure on file
Kevin Patel Mr. Patel has nothing to disclose.
Danielle Alyssa Reynolds, MD Dr. Reynolds has nothing to disclose.
Matthew A. Stults-Kolehmainen, PhD Dr. Stults-Kolehmainen has nothing to disclose.
Brian Koo, MD Dr. Koo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Regent. Dr. Koo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Speckhals Law. The institution of Dr. Koo has received research support from Department of Defense.
Paul McKee Mr. McKee has nothing to disclose.
Amanda L. Divin, PhD Dr. Divin has nothing to disclose.
Sanaz Nosrat, PhD Dr. Nosrat has nothing to disclose.
Susannah Williamson, PhD Dr. Williamson has nothing to disclose.
John Krantz, PhD Dr. Krantz has nothing to disclose.
Regina Casper, MD Prof. Casper has nothing to disclose.
Miguel Blacutt Mr. Blacutt has nothing to disclose.
Fabio Amador Bueno, RN Mr. Amador Bueno has nothing to disclose.
Riley Quinn Avila, Other Mr. Avila has nothing to disclose.
Sachin Agarwal, MD,MPH Dr. Agarwal has nothing to disclose.
Mohamed Ibrahim Abdul Aleem, MD, FAAN Dr. Aleem has nothing to disclose.
Rajani Sebastian, PhD No disclosure on file
Chintha Venkata Sriram, MBBS, MD Dr. Sriram has nothing to disclose.
Atanu Biswas, MD Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for INTAS Pharmaceuticals. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for lupin Limited. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostic. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Health N U.
Arijit Roy, Other,MBBS,MD Dr. Roy has nothing to disclose.
Adreesh Mukherjee, MD Dr. Mukherjee has nothing to disclose.
Cameron Davis, MS No disclosure on file
Anooshah Ata, MD Dr. Ata has nothing to disclose.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Malgorzata Jaremko, PhD No disclosure on file
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Stephane Saubadu, MD Dr. Saubadu has received personal compensation for serving as an employee of Sanofi. Dr. Saubadu has stock in Sanofi.
Philippe Truffinet, MD Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
Benoit Arnould, PhD Mr. Arnould has received personal compensation for serving as an employee of Sanofi. Mr. Arnould has received personal compensation for serving as an employee of ICON. Mr. Arnould has stock in Sanofi.
Natalia Hawken Dr. Hawken has received personal compensation for serving as an employee of Sanofi.
Charles A. Minor, Other Mr. Minor has received personal compensation for serving as an employee of Sanofi.
Lita Araujo, PhD Dr. Araujo has received personal compensation for serving as an employee of Sanofi Genzyme.
Samuel Gourlain, Other Mr. Gourlain has nothing to disclose.
Jérôme Msihid Mr. Msihid has received personal compensation for serving as an employee of Sanofi. Mr. Msihid has stock in Sanofi. Mr. Msihid has received intellectual property interests from a discovery or technology relating to health care. Mr. Msihid has received intellectual property interests from a discovery or technology relating to health care.
Brian Sansoucy No disclosure on file
Shuvro Roy, MD Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Scott Douglas Newsome, DO, FAAN Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from The Stiff Person Syndrome Research Foundation. The institution of Dr. Newsome has received research support from Lundbeck. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Janel Haughton, RN Mrs. Haughton has nothing to disclose.
Sat Dev Batish, PhD, FAAN Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Lawrence P. Goldstick, MD Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for genentech. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi Aventis genzyme. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for emd serono. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TGA therapeutics. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for emd serono. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis genzyme. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers Squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TGA therapeutics. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for bristol meyers squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for genentech. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi aventis genzyme. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for emd serono. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TGA therapeutics. The institution of Dr. Goldstick has received research support from biogen. The institution of Dr. Goldstick has received research support from lily. The institution of Dr. Goldstick has received research support from sanofi Aventis genzyme. The institution of Dr. Goldstick has received research support from genetech.
Ben Townsend, PhD Dr. Townsend has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Townsend has received stock or an ownership interest from F. Hoffmann-La Roche Ltd.
Dusanka Zecevic, MD Mrs. Zecevic has nothing to disclose.
Aisha Augustin, PhD Dr. Augustin has received personal compensation for serving as an employee of Roche.
Catarina Figueiredo, PhD Dr. Figueiredo has received personal compensation for serving as an employee of Roche. Dr. Figueiredo has stock in Roche.
Susanne Clinch Susanne Clinch has received personal compensation for serving as an employee of Roche Products Limited. Susanne Clinch has stock in F.Hoffman-La Roche Ltd.
Caroline Giacobino, PhD Miss Giacobino has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd.. Miss Giacobino has stock in F. Hoffmann-La Roche Ltd..
Oscar Bortolami, PhD Dr. Bortolami has received personal compensation for serving as an employee of Roche. Dr. Bortolami has received personal compensation in the range of $500-$4,999 for serving as a Statistical Reviewer with Emergency Medicine Journal.
Yun-An Shen Ms. Shen has received personal compensation for serving as an employee of Genentech. Ms. Shen has stock in Roche. Ms. Shen has received intellectual property interests from a discovery or technology relating to health care.
Heidemarie Kletzl Heidemarie Kletzl has received personal compensation for serving as an employee of Hoffmann-La Roche.
Robert A. Bermel, MD, FAAN Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck Serono. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Priya Singh No disclosure on file
Christopher C. LaGanke, MD Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GSK. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono EMD. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Ryan Shannon, NP Mr. Shannon has received personal compensation for serving as an employee of EMD Serono. Mr. Shannon has received personal compensation for serving as an employee of Biogen Idec. Mr. Shannon has received personal compensation for serving as an employee of TG Therapeutics. Mr. Shannon has received personal compensation for serving as an employee of EMD Serono. Mr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Mr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Mr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Mr. Shannon has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Mr. Shannon has a non-compensated relationship as a Consultant with EMD Serono that is relevant to AAN interests or activities.
Jim Browen Jim Browen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Zhenyuan Wang, PhD Dr. Wang has nothing to disclose.
Lana Zhovtis Ryerson, MD Dr. Zhovtis Ryerson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zhovtis Ryerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Zhovtis Ryerson has received research support from Biogen. The institution of Dr. Zhovtis Ryerson has received research support from Genentech.
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Gary Raymond Cutter, PhD Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Ryan Metzger, PhD An immediate family member of Dr. Metzger has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Metzger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Interpro Bioscience. An immediate family member of Dr. Metzger has stock in Ascendis. An immediate family member of Dr. Metzger has stock in Neurocrine Biosciences.
Judith Goldberg The institution of Judith Goldberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amarin. The institution of Judith Goldberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Asieris. Judith Goldberg has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Statistical Science and Technology Associates, Inc..
Xiaochun Li Xiaochun Li has nothing to disclose.
Evan Riddle, PhD Dr. Riddle has received personal compensation for serving as an employee of Biogen. Dr. Riddle has received stock or an ownership interest from Biogen.
Karen Smirnakis Karen Smirnakis has received personal compensation for serving as an employee of Biogen. Karen Smirnakis has received stock or an ownership interest from Biogen.
Rose M. Domingo-Horne, MD Dr. Domingo-Horne has received personal compensation for serving as an employee of Biogen. Dr. Domingo-Horne has stock in Biogen.
Susie Sinks, PhD Mrs. Sinks has received personal compensation for serving as an employee of Biogen .
Tyler Lasky Tyler Lasky has received personal compensation for serving as an employee of Biogen. Tyler Lasky has stock in Biogen.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Motric Bio.
Brandon Brown No disclosure on file
Elizabeth Camacho Elizabeth Camacho has received personal compensation for serving as an employee of Novartis .
Roland G. Henry, PhD Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
Rebecca Piccolo, PhD Dr. Piccolo has received personal compensation for serving as an employee of Novartis. Dr. Piccolo has stock in Novartis.
Le Hua, MD, FAAN Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapuetics. The institution of Dr. Hua has received research support from Biogen.
Kaylan Burnham No disclosure on file
Thomas Alois Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
William M. Carroll, MBBS,MD,FRACP,FAAN Dr. Carroll has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Mark S. Freedman, MD, FAAN Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Trygve Holmoy, MD Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Norwegian MS Society. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Rana Karabudak, MD Dr. Karabudak has nothing to disclose.
Joep Killestein Joep Killestein has nothing to disclose.
Carlos Nos, MD Dr. Nos has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffmann-La Roche Ltd..
Ludo J. Vanopdenbosch, MD, FAAN Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F Hoffmann La Roche. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Thomas Kuenzel Thomas Kunzel has received personal compensation for serving as an employee of Roche.
Karen Kadner Karen Kadner has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd.
Inessa Kulyk Inessa Kulyk has received personal compensation for serving as an employee of Roche. Inessa Kulyk has stock in Roche.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Bruno Brochet, MD, FEAN Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Joseph J. Higgins, MD, FAAN No disclosure on file
Francesca Ammoscato Francesca Ammoscato has nothing to disclose.
Justyna Skonieczna No disclosure on file
Jonathan Bestwick Jonathan Bestwick has nothing to disclose.
David Holden David Holden has nothing to disclose.
Mohammad Aboulwafa, MD Dr. Aboulwafa has nothing to disclose.
Michael *Use 400834 Andrews, MBBS Dr. Andrews has nothing to disclose.
Benjamin Turner Benjamin Turner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono.
Monica Marta Monica Calado-Marta has nothing to disclose.
Klaus Schmierer, MD, PhD Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
David Baker David Baker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. David Baker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. David Baker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. David Baker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche.
Sharmilee Gnanapavan, MB Dr. Gnanapavan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Gnanapavan has received research support from NIHR.
Jennifer Vannest No disclosure on file
Dania Mallick, MBBS Dr. Mallick has nothing to disclose.
Nicholas Lannen, MD Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech. Dr. Lannen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for TG Therapeutics. Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon Theraputics.
Thomas Maloney No disclosure on file
Catherine Tauro, DO Dr. Tauro has nothing to disclose.
Asaff Harel, MD Dr. Harel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute.
Benjamin Kay, MD No disclosure on file
Yan Xu Ms. Xu has nothing to disclose.
Denison Kuruvilla, PhD Mr. Kuruvilla has received personal compensation for serving as an employee of Genentech. Mr. Kuruvilla has stock in Genentech.
John Ratchford, MD Dr. Ratchford has received personal compensation for serving as an employee of Genentech. Dr. Ratchford has stock in F. Hoffman La-Roche.
Qi Qi, PhD Dr. Qi has nothing to disclose.
Lin Pan, PhD Dr. Pan has nothing to disclose.
Jiajie Yu, PhD Dr. Yu has received personal compensation for serving as an employee of Roche/Genentech.
Miriam Siegel No disclosure on file
Krzysztof W. Selmaj Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Jennifer L. Reardon Jennifer L. Reardon has received personal compensation for serving as an employee of Bristol Myers Squibb.
Andrew Thorpe No disclosure on file
Jon V. Riolo, PhD Dr. Riolo has received personal compensation for serving as an employee of Bristol Myers Squib.
Chun-Yen Cheng, Other Mr. Cheng has received personal compensation for serving as an employee of Bristol Myers Squibb. Mr. Cheng has stock in Bristol Myers Squibb.
James K. Sheffield, MD Dr. Sheffield has received personal compensation for serving as an employee of BMS.
Anthony Krakovich, MD Dr. Krakovich has received personal compensation for serving as an employee of BMS.
Jane B. Allendorfer, PhD An immediate family member of Dr. Allendorfer has received personal compensation for serving as an employee of Northport Health Services, LLC. The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. The institution of Dr. Allendorfer has received research support from LivaNova, Inc. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International League Against Epilepsy. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to AAN interests or activities.
Lawrence Steinman, MD, FAAN Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/Actelion. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech. The institution of Dr. Bar-Or has received research support from Merck/EMD Serono.
Sarah Harris Sarah Harris has received personal compensation for serving as an employee of BMS. Sarah Harris has stock in BMS.
Christi Banks No disclosure on file
Robert T. Naismith, MD, FAAN Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Filterlex. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for 3D Communications. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Live. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Sarah Anne Morrow, MD, MSC, FRCPC, FAAN Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIogen Idec. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMDSerono/Merck. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS/Celgene. The institution of Dr. Morrow has received research support from EMD Serono. The institution of Dr. Morrow has received research support from Novartis. The institution of Dr. Morrow has received research support from Roche. The institution of Dr. Morrow has received research support from Celgene.
Ann D. Bass, MD Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, EMD Serono, Roche-Genentech, Sanofi-Genzyme, BMS, Horizon Therapeutics, TG Therapeutics, Alexion. Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, EMD Serono, Roche-Genentech, Sanofi-Genzyme, BMS, Horizon Therapeutics, TG Therapeutics, Alexion. Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen, EMD Serono, Roche-Genentech, Sanofi-Genzyme, BMS, Horizon Therapeutics, TG Therapeutics, Alexion. The institution of Dr. Bass has received research support from Biogen, EMD Serono, Roche-Genentech, Sanofi-Genzyme, BMS, TG Therapeutics, Alexion.
Ahmed Z. Obeidat, MD, PhD Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities.
Emily S. Riser, MD Dr. Riser has nothing to disclose.
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Massimiliano Cristofanilli, PhD No disclosure on file
Burhan Zafar Chaudhry, MD Dr. Chaudhry has received personal compensation for serving as an employee of Bristol Myers Squibb.
Kamran Mohiuddin, MD Dr. Mohiuddin has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Mohiuddin has stock in Bristol Myers Squibb.
John DeLuca, PhD, ABPP Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Jerzy P. Szaflarski, MD, PhD, FAAN Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Timothy Spelman Timothy Spelman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Jan Harald Aarseth, PhD Mr. Aarseth has nothing to disclose.
Elisabeth Gulowsen Celius, MD Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Celius has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Stig Wergeland, MD, PhD Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Wergeland has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Wergeland has received research support from Biogen.
Melinda Magyari, MD Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Elisabeth Framke, PhD Dr. Framke has nothing to disclose.
Namita Tundia, PhD Mrs. Tundia has received personal compensation for serving as an employee of EMD Serono.
Schiffon Wong Schiffon Wong has received personal compensation for serving as an employee of EMD Serono.
Jan A. Hillert, MD Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Yoshie A. Umemura, MD Dr. Umemura has received personal compensation for serving as an employee of Dignity Health. Dr. Umemura has received personal compensation for serving as an employee of University of Michigan. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Umemura has received research support from Gateway for Cancer Research.
Galina Vorobeychik, MD, FRCPC, FAAN Dr. Vorobeychik has nothing to disclose.
Himali Bergeron-Vitez Miss Bergeron-Vitez has nothing to disclose.
Jill R. Nelson, RN Ms. Nelson has nothing to disclose.
Anna Kazimirchik, RN Mrs. Kazimirchik has nothing to disclose.
Thomas Andrew No disclosure on file
Bade Gulec Bade Gulec has nothing to disclose.
Elif Everest, PhD Ms. Everest has received personal compensation in the range of $50,000-$99,999 for serving as a postdoctoral visiting fellow with National Institutes of Health.
Melih Tutuncu, MD Melih Tutuncu has nothing to disclose.
Sabahattin Saip Sabahattin Saip, 6729 has nothing to disclose.
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Ugur Uygunoglu Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey.
Ogeday Derin Gorkey, MD Dr. Gorkey has nothing to disclose.
Metehan Koc, MD Dr. Koc has nothing to disclose.
Valerie Jacobs No disclosure on file
Thomas Doerner, MD Prof. Doerner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Prof. Doerner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/GNE. Prof. Doerner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Warner Carr, MD The institution of Dr. Carr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Carr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. The institution of Dr. Carr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eyevance Pharmaceuticals. The institution of Dr. Carr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . The institution of Dr. Carr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Carr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. The institution of Dr. Carr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Carr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Carr has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Carr has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Regeneron. The institution of Dr. Carr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Carr has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Prollergy.
Koremasa Hayama, MD,PhD Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharma. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Hayama has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Dr. Hayama has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lill. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen Pharma. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kaken Pharma. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyorin. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa-Kirin. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Maruho. Dr. Hayama has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitubishi-Tanabe. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nihon Pharmaceutical. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Taiho. Dr. Hayama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Hayama has received publishing royalties from a publication relating to health care. Dr. Hayama has received publishing royalties from a publication relating to health care.
Michihiro Hide, MD,PhD Dr. Hide has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teikoku Seiyaku. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kaken Pharmaceutical. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa-Kirin. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Taiho. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyorin. The institution of Dr. Hide has received research support from Japan and Grant-in-Aid for Scientific Research.
Marcus Maurer Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astria. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioCryst. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Blueprint. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celldex. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kalvista. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharvaris. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Regeneron. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Marcus Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ThirdHarmonicBio. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noucor. Marcus Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Septerna. Marcus Maurer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Marcus Maurer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Phavaris. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Marcus Maurer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celldex. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Gordon Sussman, MD Dr. Sussman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Sussman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sussman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NexGen. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Toleranzia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Swapnil Suhas Dahale Mr. Dahale has nothing to disclose.
Virginia DeLasHeras Virginia DeLasHeras has received personal compensation for serving as an employee of NOVARTIS.
Sibylle Haemmerle, PhD Dr. Haemmerle has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Haemmerle has stock in Novartis Pharma AG.
Bernd C. Kieseier, MD Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Karine Lheritier, PhD Dr. Lheritier has received personal compensation for serving as an employee of Novartis. Dr. Lheritier has stock in Novartis.
Artem Zharkov, MD Dr. Zharkov has received personal compensation for serving as an employee of Novartis. Dr. Zharkov has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Zharkov has received personal compensation for serving as an employee of SOBI. Dr. Zharkov has stock in Novartis.
Roman Willi, PhD Dr. Willi has received personal compensation for serving as an employee of Novartis Pharma. Dr. Willi has received stock or an ownership interest from Novartis.
Ana M. Gimenez-Arnau, MD,PhD Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uriach Pharma. Prof. Gimenez-Arnau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAnofi Regeneron . Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thermo Fisher . Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CElldex . Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Uriach Pharma. Prof. Gimenez-Arnau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Prof. Gimenez-Arnau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi . Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Menarini . The institution of Prof. Gimenez-Arnau has received research support from Instituto CArlos III. The institution of Prof. Gimenez-Arnau has received research support from URIACH . The institution of Prof. Gimenez-Arnau has received research support from NOVARTIS . Prof. Gimenez-Arnau has received publishing royalties from a publication relating to health care.
Joyce Oleszek No disclosure on file
Pamela M. Rist, PhD The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital.
Samantha Mora Ms. Mora has nothing to disclose.
Taylor McVeigh, Other Miss McVeigh has nothing to disclose.
Christine Westfield No disclosure on file
Cesar Eduardo Escamilla-Ocanas, MD Dr. Escamilla-Ocanas has nothing to disclose.
Noelia Cristina Morales, MD Dr. Morales has nothing to disclose.
Rahul Damani Rahul Damani has nothing to disclose.
Eric Bershad, MD Dr. Bershad has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various.
Mohammad I. Hirzallah, MD Dr. Hirzallah has nothing to disclose.
Khawja Ahmeruddin Siddiqui, MD Dr. Siddiqui has nothing to disclose.
Chethan K. Venkatasubba Rao, MD Dr. Venkatasubba Rao has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Maestro Inc.
Muhammad Shahzad Zafar, MBBS Dr. Zafar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Zafar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova . The institution of Dr. Zafar has received research support from UCB. The institution of Dr. Zafar has received research support from SK life. The institution of Dr. Zafar has received research support from Marinus. The institution of Dr. Zafar has received research support from LivaNova. The institution of Dr. Zafar has received research support from Biopharma. The institution of Dr. Zafar has received research support from Neurocrine. The institution of Dr. Zafar has received research support from Hartwell Foundation.
Atul Phillips, MBBS,MD Dr. Phillips has nothing to disclose.
Jeyaraj Durai Pandian, MD, DM Dr. Pandian has nothing to disclose.
Maximiliano Alberto Hawkes, MD Dr. Hawkes has nothing to disclose.
Adnan I. Qureshi, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Adam De Havenon, MD, FAAN Dr. De Havenon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has stock in Certus. Dr. De Havenon has stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Alejandra Maria Stewart, MD No disclosure on file
Joyeta Razzaque, MBBS Dr. Razzaque has nothing to disclose.
Syed Muhammad Owais Mr. Owais has nothing to disclose.
Hira Pervez, MD, MBBS Dr. Pervez has nothing to disclose.
Vinh Pham, MD Dr. Pham has nothing to disclose.
Sahil Sakibuzzaman, MD Dr. Sakibuzzaman has nothing to disclose.
Mohammad Mahmoud Samara, MD Dr. Samara has nothing to disclose.
Vicki A. Ramsey-Williams, MD, PhD Dr. Ramsey-Williams has nothing to disclose.
Bashar Saour, MD Dr. Saour has nothing to disclose.
Elysia James, MD Dr. James has nothing to disclose.
Claire *Use 397163 Popovich Miss Popovich has nothing to disclose.
Robert J. Baumann, MD, FAAN Dr. Baumann has nothing to disclose.
Chelsea Sykora Ms. Sykora has nothing to disclose.
Cameron Hill Mr. Hill has nothing to disclose.
Charlene Jennifer Ong, MD Dr. Ong has nothing to disclose.
Min Shin Min Shin has nothing to disclose.
Stephen Schmugge, Other Mr. Schmugge has nothing to disclose.
Samuel Tate Samuel Tate has received personal compensation in the range of $50,000-$99,999 for serving as a Senior Software Engineer with University of North Carolina at Charlotte.
Joseph Sisto, Other Mr. Sisto has nothing to disclose.
Michael Francis Maimon Cronin The institution of Mr. Cronin has received research support from American Heart Association.
Paul W. O'Connor, MD No disclosure on file
Katherine Michelle Clifford, MD Dr. Clifford has nothing to disclose.
Miriam L. Freimer, MD, FAAN Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presenations/teaching with UCB.
Neelam Goyal, MD Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/ Ra Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze Therapeutics. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes of Health. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neuromuscular Disease Foundation. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi-Genzyme. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Spark Therapeutics. The institution of Dr. Mozaffar has received research support from Audentes Therapeutics. The institution of Dr. Mozaffar has received research support from Cartesian. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Pushpa Narayanaswami, MBBS, MD, FAAN Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has stock in Moderna. Dr. Narayanaswami has stock in Dr. Reddys laboratories. Dr. Narayanaswami has stock in Pfizer. Dr. Narayanaswami has stock in Viatris. Dr. Narayanaswami has stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. Dr. Narayanaswami has a non-compensated relationship as a Member, Medical and Scientific Advisory Board with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Narayanaswami has a non-compensated relationship as a Member, Board of Directors with AANEM that is relevant to AAN interests or activities.
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Anahit C. Mehrabyan, MD Dr. Mehrabyan has nothing to disclose.
Amanda C. Guidon, MD An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Guidon has received research support from MGFA. The institution of Dr. Guidon has received research support from Project Data Sphere. The institution of Dr. Guidon has received research support from MGNet. The institution of Dr. Guidon has received research support from MGNet. Dr. Guidon has received publishing royalties from a publication relating to health care.
Michael K. Hehir, II, MD Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Hehir has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum- American Academy of Neurology. Dr. Hehir has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Hehir has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. Hehir has received research support from University of Vermont Medical Center.
Ali A. Habib, MD Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Immune Sciences. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from VielaBio. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Genentech. The institution of Dr. Habib has received research support from Regeneron.
Dave Siu Kwan Ho, MD Dr. Ho has stock in Moderna.
Samantha Blum, DO Dr. Blum has nothing to disclose.
Karen Tu No disclosure on file
Guido Sabatella Guido Sabatella has received personal compensation for serving as an employee of Alexion.
Andrew J. Gordon, MD Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion . Dr. Gordon has received personal compensation in the range of $0-$499 for serving as a Consultant for Vertex. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cassiday.
Michael T. Pulley, MD, PhD Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion`. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pulley has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple law firms.
Saida Sharapova Dr. Sharapova has nothing to disclose.
James F. Howard, Jr., MD, FAAN Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for arenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ra Pharma (now UCB Biosciences). Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi US. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Zai Laboratories. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medscape CME. Dr. Howard has stock in General Electric dividends. Dr. Howard has stock in Johnson & Johnson dividends. Dr. Howard has stock in Pfizer dividends. An immediate family member of Dr. Howard has stock in GlaxoSmithKline dividends. An immediate family member of Dr. Howard has stock in GE Healthcare dividends. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Duke University (DCRI). The institution of Dr. Howard has received research support from Cartestian Therapeutics. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Akshay Mahesh Shah, MD No disclosure on file
Zabeen Kaizar Mahuwala, MD, FAAN Dr. Mahuwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant.
Julian Grosskreutz Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grosskreutz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. The institution of Dr. Grosskreutz has received research support from Boris Canessa Foundation.
Renato Mantegazza, MD Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Robert M. Pascuzzi, MD, FAAN Dr. Pascuzzi has nothing to disclose.
Sabrina Sacconi, MD Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMICUS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FULCRUM THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AXELYS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OLOGY. The institution of Dr. Sacconi has received research support from Solve FSHD.
John Vissing, MD Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genethon. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lupin. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from UCB Pharma. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from NOVO Foundation. Prof. Vissing has received research support from Reneo Pharma. Prof. Vissing has received research support from Janssen Pharmaceuticals.
Tuan Hoang Vu, MD Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImmunAbs. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from Amylyx Pharma. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Annexon. The institution of Dr. Vu has received research support from Horizon. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Momenta. The institution of Dr. Vu has received research support from Immunovant.
Raphaelle Beau Lejdstrom, PhD Dr. Beau Lejdstrom has received personal compensation for serving as an employee of UCB Pharma.
Bernhard Greve, MD Dr. Greve has received personal compensation for serving as an employee of UCB Biosciences. Dr. Greve has stock in UCB Biosciences.
Fiona Grimson, PhD Dr. Grimson has received personal compensation for serving as an employee of UCB Pharma. Dr. Grimson has stock in UCB Pharma.
Thais Tarancon Heras, Sr., MD Dr. Heras has received personal compensation for serving as an employee of UCB Pharma S.A.
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Nicolaas C. Anderson, DO Dr. Anderson has nothing to disclose.
Olivia Tong, MD Dr. Tong has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Torry Cong, PhD Mr. Cong has received personal compensation for serving as an employee of Alexion.
Alanna McEneny, PhD Dr. McEneny has received personal compensation for serving as an employee of Alexion Pharmaceuticals Inc.. Dr. McEneny has stock in Alexion Pharmaceuticals.
Min Yee, Other Dr. Yee has nothing to disclose.
Kendra Drake, MD, FAAN Dr. Drake has nothing to disclose.
Maria Proytcheva No disclosure on file
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Bhupendra O. Khatri, MD, FAAN Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen.
Todd D. Levine, MD Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has stock in CND Life Sciences. Dr. Levine has stock in Corinthian reference lab.
Babak Boroojerdi, MD Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCb Biosciences.
Eumorphia Maria DELICHA, PhD Dr. DELICHA has nothing to disclose.
Brittany Harvey, Other Ms. Harvey has received personal compensation for serving as an employee of UCB. Ms. Harvey has a non-compensated relationship as a Board Member with ALS Association Florida Chapter that is relevant to AAN interests or activities.
Andreea Lavrov, MD Dr. Lavrov has received personal compensation for serving as an employee of UCB Biosciences GmbH. An immediate family member of Dr. Lavrov has received personal compensation for serving as an employee of UCB Biosciences GmbH. Dr. Lavrov has stock in UCB Biosciences GmbH. An immediate family member of Dr. Lavrov has stock in UCB Biosciences GmbH.
Bruce M. Coull, MD Dr. Coull has nothing to disclose.
Jana Podhorna, MD,PhD Dr. Podhorna has received personal compensation for serving as an employee of argenx. Dr. Podhorna has stock in argenx.
Charlotte E. Ward, PhD Dr. Ward has nothing to disclose.
Ikjae Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lee has received personal compensation in the range of $0-$499 for serving as a Consultant for Amylyx. Dr. Lee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. The institution of Dr. Lee has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. Lee has received research support from CReATe consortium/American Brain Foundation. The institution of Dr. Lee has received research support from NIH.
Yuebing Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Li has received research support from Argenx.
Tobias Ruck, MD Dr. Ruck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme.
Elizabeth Teperov, MD Dr. Teperov has received personal compensation for serving as an employee of argenx.
Ami Anand Shah, MD Dr. Shah has nothing to disclose.
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has stock in argenx.
Stela Lefter, MD No disclosure on file
Denis Korobko, MD,PhD Dr. Korobko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Korobko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Korobko has received personal compensation in the range of $0-$499 for serving as a Consultant for Sanofi. Dr. Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Dr. Korobko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen (Johnson & Johnson company). Dr. Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen (Johnson & Johnson company).
Sophie Steeland, PhD,Other Mrs. Steeland has nothing to disclose.
Benjamin Van Hoorick, MD Dr. Van Hoorick has received personal compensation for serving as an employee of argenx.
Moana Hodari, MD Mrs. Hodari has nothing to disclose.
Kimiaki Utsugisawa, MD,PhD Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Francesco Sacca, MD Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Jan L. De Bleecker, MD, PhD, FAAN Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals.
Lauren B. Elman, MD Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Elman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharamaceuticals. Dr. Elman has received publishing royalties from a publication relating to health care.
Hiroyuki Murai, MD Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. The institution of Dr. Murai has received research support from Japan Blood Products Organization.
Glenn A. Phillips, PhD Dr. Phillips has received personal compensation for serving as an employee of argenx. Dr. Phillips has stock in argenx.
Cynthia Zhengyun Qi, Other Ms. Qi has received personal compensation for serving as an employee of argenx.
Deborah Gelinas, MD Dr. Gelinas has received personal compensation for serving as an employee of argenx. Dr. Gelinas has stock in argenx.
Edward Brauer Edward Brauer has received personal compensation for serving as an employee of argenx. Edward Brauer has stock in argenx.
Sihui Zhao Sihui Zhao has received personal compensation for serving as an employee of AbbVie. Sihui Zhao has received stock or an ownership interest from AbbVie.
Nabila Dahodwala, MD, FAAN Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genetech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Yessar M. Hussain, MD The institution of Dr. Hussain has received research support from Alnylam Pharma.
Kelly G. Gwathmey, MD Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Gregory Sahagian, MD, FAAN Dr. Sahagian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sahagian has received intellectual property interests from a discovery or technology relating to health care.
Kristl Claeys, MD, PhD Dr. Claeys has nothing to disclose.
Elena Cortes-Vicente, MD,PhD Dr. Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx BV. Dr. Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB pharma. Dr. Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx BV. Dr. Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma.
Anne Sumbul Mrs. Sumbul has received personal compensation for serving as an employee of argrenx.
Rosa Herminia Jimenez, MD, PhD Dr. Jimenez has nothing to disclose.
Daniela Hristova, MBBS Dr. Hristova has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for argenx.
Kelly Almasy No disclosure on file
Justin Lee, PhD Mr. Lee has received personal compensation for serving as an employee of Alexion. Mr. Lee has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Alexion.
Karen Yee, PhD Dr. Yee has received personal compensation for serving as an employee of Alexion. Dr. Yee has stock in Alexion. Dr. Yee has stock in Takeda.
Michael Blackowicz, PhD Dr. Blackowicz has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Blackowicz has stock in Alexion Pharmaceuticals.
Ema Rodrigues, Other Dr. Rodrigues has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Rodrigues has stock in Alexion Pharmaceuticals.
Ashley Yegin Dr. Yegin has received personal compensation for serving as an employee of Alexion, Astra Zeneca Rare Disease. Dr. Yegin has stock in Alexion, Astra Zeneca Rare Disease.
Mary Kelley No disclosure on file
Mohamed Khateb, MD, PhD Dr. KHATEB has nothing to disclose.
Shahar Shelly, MD Dr. Shelly has nothing to disclose.
David Yarnitsky, MD Dr. Yarnitsky has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International association for the study of pain.
Leo McCluskey, MD No disclosure on file
Charlotte Engebrecht, Other Ms. Engebrecht has nothing to disclose.
Spencer Rosero Mr. Rosero has nothing to disclose.
Shaweta Khosa, MD Dr. Khosa has nothing to disclose.
Jennifer Weinstein Jennifer Weinstein has nothing to disclose.
Jamison Seabury, Other Ms. Seabury has nothing to disclose.
Anika Varma, Other Miss Varma has nothing to disclose.
Christina Shupe, Other Ms. Shupe has nothing to disclose.
Charlotte Irwin, Other Ms. Irwin has nothing to disclose.
Alicia Brocht Mrs. Brocht has nothing to disclose.
Olimpia Carbunar, MD The institution of Dr. Carbunar has received research support from National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Chad R. Heatwole, MD, FAAN Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Legal Med. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $0-$499 for serving as a Consultant for Iris. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for New York Central Mutual. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Penn Prop and Gas. The institution of Dr. Heatwole has received research support from Department of Defense. The institution of Dr. Heatwole has received research support from Novartis. The institution of Dr. Heatwole has received research support from MJFF. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from University of Miami. The institution of Dr. Heatwole has received research support from MDA. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care.
Vishnu Parthasarathy No disclosure on file
Nakul Katyal, MD Dr. Katyal has nothing to disclose.
Martavius T. Lovall, MD An immediate family member of Dr. Lovall has received personal compensation for serving as an employee of Sylllable .
Darvis Frazier No disclosure on file
Chongbo Zhao, MD Dr. Zhao has nothing to disclose.
Immaculada Aban Immaculada Aban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Immaculada Aban has received research support from NIH. The institution of Immaculada Aban has received research support from Myasthenia Gravis Foundation of America (MGFA). The institution of Immaculada Aban has received research support from Ra Pharmaceutical through MGFA. The institution of Immaculada Aban has received research support from Alexion through MGFA. The institution of Immaculada Aban has received research support from ArgenX through MGFA. The institution of Immaculada Aban has received research support from Catalyst through MGFA. The institution of Immaculada Aban has received research support from Verona. Immaculada Aban has received personal compensation in the range of $0-$499 for serving as a Data Safety Monitoring Board member with NIH NIAMS. Immaculada Aban has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with NIH NINDS.
MARCONDES *Use 140311 CAVALCANTE FRANCA, Jr. Dr. CAVALCANTE FRANCA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. CAVALCANTE FRANCA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. CAVALCANTE FRANCA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. CAVALCANTE FRANCA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. CAVALCANTE FRANCA has received research support from FARA.
Jorge Gustavo Jose Jorge Gustavo Jose has received personal compensation for serving as an employee of hospital padilla. Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis, . Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving as a Consultant for RAFFO. Jorge Gustavo Jose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVARTIS. Jorge Gustavo Jose has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Jorge Gustavo Jose has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for MERCK. Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ROCHE. The institution of Jorge Gustavo Jose has received research support from NOVARTIS. Jorge Gustavo Jose has received research support from ROCHE. Jorge Gustavo Jose has received research support from SANOFI.
Gerd Meyer Zu Horste, MD Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB. The institution of Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Meyer Zu Horste has received research support from Merck KGaA. The institution of Dr. Meyer Zu Horste has received research support from Roche. Dr. Meyer Zu Horste has received intellectual property interests from a discovery or technology relating to health care.
Elzbieta Klimiec Ms. Klimiec has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medison Pharma.
Dario Raul Tavolini Dario Raul Tavolini has nothing to disclose.
Petranka Krumova Petranka Krumova has received personal compensation for serving as an employee of F. Hoffmann-La Roche. Petranka Krumova has stock in F.Hoffmann-La Roche.
Sian Lennon-Chrimes Sian Lennon-Chrimes has received personal compensation for serving as an employee of Roche Products Ltd. Sian Lennon-Chrimes has stock in Roche Products Ltd. Sian Lennon-Chrimes has received intellectual property interests from a discovery or technology relating to health care.
Jillian Smith Jillian Smith has received personal compensation for serving as an employee of Roche Products Ltd. Jillian Smith has stock in Roche Holdings. Jillian Smith has received intellectual property interests from a discovery or technology relating to health care.
Ivana Vodopivec, MD Dr. Vodopivec has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Vodopivec has received personal compensation for serving as an employee of Novartis. Dr. Vodopivec has stock in Roche.
Gian-Andrea Thanei Gian-Andrea Thanei has received personal compensation for serving as an employee of Roche. Gian-Andrea Thanei has stock in Roche.
Gil I. Wolfe, MD, FAAN Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from ArgenX. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Laura Jastrzab No disclosure on file
Narayani Wagle, Other Ms. Wagle has nothing to disclose.
Preetham Bachina Mr. Bachina has nothing to disclose.
Goknur Selen Kocak, MD Dr. Kocak has nothing to disclose.
Andrea M. Corse, MD Dr. Corse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Corse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Corse has received personal compensation in the range of $0-$499 for serving as a grant reviewer with FDA.
Nurten Uzun Adatepe No disclosure on file
Kemar Earl Green, DO Dr. Green has nothing to disclose.
Linda Chao No disclosure on file
Shota Miyake Mr. Miyake has received personal compensation for serving as an employee of Chugai Pharmaceutical Co.,Ltd.
Kenichi Serizawa, PhD Dr. Serizawa has received personal compensation for serving as an employee of Chugai Pharmaceutical Co., Ltd.
Shinichi Onishi, Other Mr. Onishi has nothing to disclose.
Yoshichika Katsura, PhD Mr. Katsura has received personal compensation for serving as an employee of Chugai Pharmaceutical CO., LTD..
Masayuki Baba, PhD Dr. Baba has received personal compensation for serving as an employee of Chugai Pharmaceutical Co., Ltd..
MITSUE KURASAWA, Other Ms. KURASAWA has nothing to disclose.
Haruna Tomizawa-Shinohara, PhD Ms. Tomizawa-Shinohara has received personal compensation for serving as an employee of Chugai Pharmaceutical Co., Ltd..
Keigo Yorozu, PhD Dr. Yorozu has nothing to disclose.
YOSHIHIRO MATSUMOTO, Other Mr. MATSUMOTO has received personal compensation for serving as an employee of Chugai Pharmaceutical Co., Ltd..
Mariko Noguchi-Sasaki, PhD Dr. Noguchi-Sasaki has received personal compensation for serving as an employee of Chugai Pharmaceutical Co., Ltd..
Helena C. Chui, MD The institution of Dr. Chui has received research support from National Institute on Aging .
Julia Helene Greenberg, MD Dr. Greenberg has a non-compensated relationship as a Editorial Board Member with Neurology Resident and Fellow Section that is relevant to AAN interests or activities.
Kiril Kiprovski, MD Dr. Kiprovski has nothing to disclose.
Sujata P. Thawani, MD Dr. Thawani has nothing to disclose.
Aravind Ganesh, MD Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MD Analytics. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MyMedicalPanel. Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as a Consultant for Figure 1. Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as a Consultant for DeepBench. An immediate family member of Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CTC Communications Corp. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as a Consultant for Research on Mind. Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as a Consultant for Creative Research Designs. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Canada. Dr. Ganesh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Let's Get Proof (Collavidence Inc). Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology (journals Neurology and Neurology: Clinical Practice). Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association (journal: Stroke). Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers (for Frontiers in Neurology). Dr. Ganesh has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Grosso Harper Law. Dr. Ganesh has stock in SnapDx. Dr. Ganesh has stock in TheRounds.com. Dr. Ganesh has stock in Advanced Health Analytics (AHA Health Ltd). Dr. Ganesh has stock in Collavidence Inc. Dr. Ganesh has stock in DataSimpl. The institution of Dr. Ganesh has received research support from Canadian Institutes of Health Research . The institution of Dr. Ganesh has received research support from Canadian Cardiovascular Society. The institution of Dr. Ganesh has received research support from Alberta Innovates. The institution of Dr. Ganesh has received research support from University of Calgary Centre for Clinical Research. The institution of Dr. Ganesh has received research support from Innovation 4 Health. The institution of Dr. Ganesh has received research support from Government of Canada INOVAIT. The institution of Dr. Ganesh has received research support from Campus Alberta Neuroscience. The institution of Dr. Ganesh has received research support from Alzheimer Society of Canada. The institution of Dr. Ganesh has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Ganesh has received research support from New Frontiers in Research Fund. The institution of Dr. Ganesh has received research support from Panmure House. The institution of Dr. Ganesh has received research support from Brain Canada. The institution of Dr. Ganesh has received research support from MSI Foundation. The institution of Dr. Ganesh has received research support from France Canada Research Fund. Dr. Ganesh has received intellectual property interests from a discovery or technology relating to health care.
Brianne Bettcher No disclosure on file
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
Caroline Brethenoux Mrs. Brethenoux has received personal compensation for serving as an employee of Cien+ .
Alyssa DeLuca Miss DeLuca has nothing to disclose.
Jacqueline Pesa, PhD Dr. Pesa has received personal compensation for serving as an employee of Janssen. Dr. Pesa has stock in J&J.
Louis Jackson, PharmD Dr. Jackson has received personal compensation for serving as an employee of Janssen Pharmaceuticals.
Patrick Furey, Jr. Mr. Furey has nothing to disclose.
Rosario Alvarez Miss Alvarez has nothing to disclose.
Laura Gonzalez Quijano Miss Gonzalez Quijano has nothing to disclose.
Alex Lorenzo Mr. Lorenzo has nothing to disclose.
Ashley E. Anderson, MD Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/Johnson&Johnson. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Zia Ulhaq Chaudhry, MD,PhD Dr. Chaudhry has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Chaudhry has received personal compensation for serving as an employee of Takeda Pharmaceuticals.
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Yingkai Li, MD, PhD Dr. Li has nothing to disclose.
Simon Gregory The institution of Simon Gregory has received research support from NIH. Simon Gregory has received intellectual property interests from a discovery or technology relating to health care. Simon Gregory has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant with David H Murdock Research Institute.
Michael Aksu No disclosure on file
Tabitha Karatz Ms. Karatz has nothing to disclose.
Vern C. Juel, MD, FAAN Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accordant Health Services. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Marites Topor No disclosure on file
Padmaja Sudhakar, MD Dr. Sudhakar has nothing to disclose.
Hailey Mair Miss Mair has nothing to disclose.
Nicholas Demas Mr. Demas has nothing to disclose.
Andrew Riddehough No disclosure on file
Nancy J. Newman, MD, FAAN Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophoenix. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Chiesi/Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Patrick Yu-Wai-Man Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GenSight Biologics.
Valerio Carelli, MD, PhD Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici.
Valerie Biousse, MD Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurophoenix. The institution of Dr. Biousse has received research support from NIH. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Catherine Vignal-Clermont Mrs. Vignal-Clermont has received personal compensation in the range of $0-$499 for serving as a Consultant for Gensight Biologics.
Francois Montestruc Mr. Montestruc has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for eXYSTAT SAS. The institution of Mr. Montestruc has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AFM Telethon.
Magali Taiel Magali Taiel has nothing to disclose.
Jose-Alain Sahel The institution of Jose-Alain Sahel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avista. The institution of Jose-Alain Sahel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tenpoint . The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF GENSIGHT. The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF SPARINGVISION. Jose-Alain Sahel has stock in Prophesee. Jose-Alain Sahel has stock in Tilak Healthcare. Jose-Alain Sahel has stock in Sparing Vision. Jose-Alain Sahel has stock in Chronolife. Jose-Alain Sahel has stock in VegaVect Inc.. Jose-Alain Sahel has stock in Avista. Jose-Alain Sahel has stock in Tenpoint. Jose-Alain Sahel has stock in SharpEye. Jose-Alain Sahel has stock in GenSight. The institution of Jose-Alain Sahel has received research support from LabEx LIFESENSES (ANR-10-LABX-65). The institution of Jose-Alain Sahel has received research support from IHU FOReSIGHT (ANR-18-IAHU-01). The institution of Jose-Alain Sahel has received research support from ERC Synergy "HELMHOLTZ". Jose-Alain Sahel has received intellectual property interests from a discovery or technology relating to health care.
Jeffrey Alger No disclosure on file
Wayne Macfadden, MD,PT Dr. Macfadden has received personal compensation for serving as an employee of Jazz pharma. Dr. Macfadden has stock in Jazz pharma.
Eileen Leary, PhD Dr. Leary has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Leary has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Proper. Dr. Leary has stock in Jazz Pharmaceuticals.
Craig Jeffrey Pfister, Other Mr. Pfister has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Pfister has stock in Jazz Pharmaceuticals.
Douglas S. Fuller Mr. Fuller has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Fuller has stock in Jazz Pharmaceuticals.
David Wharton No disclosure on file
Ramakrishna Nirogi, PhD Dr. Nirogi has nothing to disclose.
Pradeep Jayarajan Pradeep Jayarajan has nothing to disclose.
Vijay Benade, Other Mr. BENADE has nothing to disclose.
Vinod Goyal Vinod Goyal has nothing to disclose.
Anil Shinde Anil Shinde has nothing to disclose.
Jyothsna Ravula Jyothsna Ravula has nothing to disclose.
Satish Jetta Satish Jeta has nothing to disclose.
Venkat Jasti No disclosure on file
Michael J. Thorpy, MD Dr. Thorpy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Thorpy has received publishing royalties from a publication relating to health care.
Marisa Whalen Marisa Whalen has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
Yves Dauvilliers, MD, PhD Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel.
Watcharasarn Rattananan, MD No disclosure on file
Mahmoud Tarek Hefnawy Mr. Hefnawy has nothing to disclose.
Basma Ehab Amer Dr. Amer has nothing to disclose.
Samar Ahmed Amer, MD Dr. Amer has nothing to disclose.
Yehya Khlidj, MD Dr. Khlidj has nothing to disclose.
Bahaa Elfakharany, Jr., MD Dr. Elfakharany has nothing to disclose.
Khaled Abdallah Moghib Dr. Moghib has nothing to disclose.
Adel Mouffokes, MD Dr. Mouffokes has nothing to disclose.
Nishant Parag Soni Mr. Soni has nothing to disclose.
Zainab Jamal Alazzeh, MD Dr. Alazzeh has nothing to disclose.
Mohamed Elsayed Dr. Elsayed has nothing to disclose.
Jill Marie Blandford, DO No disclosure on file
Richard K. Bogan, MD Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Philips. The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Fresca. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care. Dr. Bogan has a non-compensated relationship as a Chair with National Sleep Foundation that is relevant to AAN interests or activities.
Logan D. Schneider, MD Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Cristina Casstevens Cristina Casstevens has received personal compensation for serving as an employee of Jazz Pharmaceuticals . Cristina Casstevens has stock in Jazz Pharmaceuticals.
Gwendolyn C. Claussen, MD No disclosure on file
Thomas Roth, PhD Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Roth has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz.
Giuseppe Plazzi, MD The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TAKEDA. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOPROJET. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA/CENTESSA.
Jed Black, MD Jed Black, MD has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Jed Black, MD has stock in Jazz Pharmaceuticals. Jed Black, MD has stock in .
Shin J. Oh, MD, FAAN No disclosure on file
Patrick Ziyun Liu, PhD Dr. Liu has nothing to disclose.
David M. Raizen, MD Dr. Raizen has nothing to disclose.
Carsten Skarke, MD Dr. Skarke has nothing to disclose.
Thomas Brooks, PhD Dr. Brooks has nothing to disclose.
Ron C. Anafi, MD,PhD Dr. Anafi has nothing to disclose.
Mohammad Alsharabati, MD No disclosure on file
Clete A. Kushida, MD, PhD Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XW Pharma, Inc.. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zephyr Sleep Technologies. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vivos. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebra. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co., Inc.. Dr. Kushida has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State of Arizona. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Browne George Ross, LLP. The institution of Dr. Kushida has received research support from AmCAD, Philips-Respironics, Asate, Syneos Health, Inspire. Dr. Kushida has received publishing royalties from a publication relating to health care.
Anne Marie Morse, DO,Other The institution of Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals, Harmony Biosciences, Avadel Pharmaceuticals, Takeda Pharmaceuticals, Alkermes, National Institute for Health, and Geisinger Health Plan. The institution of Dr. Morse has received research support from Harmony Biosciences, Avadel Pharmaceuticals, Takeda Pharmaceuticals, Alkermes, National Institute for Health, and Geisinger Health Plan.
John Harsh, PhD Dr. Harsh has nothing to disclose.
Luis E. Ortiz, MD Dr. Ortiz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avadel Pharmaceuticals. Dr. Ortiz has stock in NLS Pharmaceuticals. Dr. Ortiz has a non-compensated relationship as a Advisory Board Member with Sleep Consortium that is relevant to AAN interests or activities.
Jennifer Gudeman Miss Gudeman has received personal compensation for serving as an employee of Avadel Pharmaceuticals. Miss Gudeman has stock in Avadel Pharmaceuticals.
Hongyan Ding No disclosure on file
Craig Chepke Craig Chepke has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Craig Chepke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. Craig Chepke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Craig Chepke has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acadia. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Otsuka. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Takeda. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Janssen. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ironshore. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Craig Chepke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Craig Chepke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Intracellular. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Craig Chepke has received research support from Acadia. Craig Chepke has received research support from Harmony. Craig Chepke has received research support from Neurocrine.
Andrew Cutler Andrew Cutler has received personal compensation for serving as an employee of Neuroscience Education Institute. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alfasigma. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intra-Cellular Therapies. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MedAvante-ProPhase. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Noven. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sage Therapeutics. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioXcel. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corium. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karuna. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neumora. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Relmada. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for COMPASS Pathways. Andrew Cutler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Andrew Cutler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alkermes. Andrew Cutler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Intra-Cellular Therapies. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Ironshore. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Andrew Cutler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Noven. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Otsuka. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Andrew Cutler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axsome. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BioXcel. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Corium. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Tris. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neuroscience Education Institute.
Samantha Floam, DMD Dr. Floam has received personal compensation for serving as an employee of Axsome Therapeutics.
Gregory S. Parks, PhD Dr. Parks has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Parks has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Parks has stock in Axsome Therapeutics. Dr. Parks has stock in Jazz Pharmaceuticals.
Russell Rosenberg Mr. Rosenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Mr. Rosenberg has received research support from Neurotrials Research.
QIANG DONG, PhD No disclosure on file
Sophia Tsz Sum Tong Ms. Tong has nothing to disclose.
Christina Marini Ms. Marini has nothing to disclose.
Azizi Seixas Azizi Seixas has nothing to disclose.
Lisa Doan, MD Dr. Doan has nothing to disclose.
Ricardo Osorio, MD Dr. Osorio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia.
Duaa Bnayan, MD Dr. Bnayan has nothing to disclose.
Lama Hani Hatamleh, MD Dr. Hatamleh has nothing to disclose.
Monica Salmeron, MD Dr. Salmeron has nothing to disclose.
Emrah Aras, MD Dr. Aras has received personal compensation for serving as an employee of Alexion Pharmaceuticals Inc.
Marcondes C. Franca, Jr., MD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
Ibrahim Serag, MBBS Dr. Serag has nothing to disclose.
Amro Emad AbuShanab, MBBS Dr. AbuShanab has nothing to disclose.
Ahmed Abbas, MD Dr. Abbas has nothing to disclose.
Oksana Mokliatchouk Oksana Mokliatchouk has received personal compensation for serving as an employee of Biogen. Oksana Mokliatchouk has received stock or an ownership interest from Biogen.
Zahid Iqbal, MD Dr. Iqbal has nothing to disclose.
Eric Dunn, DO Dr. Dunn has nothing to disclose.
Gerard Harty Gerard Harty has received personal compensation for serving as an employee of Merck KGaA Darmstadt.
Erica Escalera Miss Escalera has nothing to disclose.
Jeffrey L. Saver, MD, FAAN Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Roxanna Nahvi, MD, PhD Dr. Nahvi has nothing to disclose.
Maresa Caunt Mrs. Caunt has received personal compensation for serving as an employee of Roche/Genentech. Mrs. Caunt has stock in Roche/Genentech.
Rodrigo Joaquin Sanjinez, Sr., MD Dr. Sanjinez has nothing to disclose.
Raphael Muszkat Besborodco, MD Dr. Besborodco has nothing to disclose.
Danna Cruz, Other Dr. Cruz has nothing to disclose.